Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCB7 ABCA4 ABCA13 ABCA9 ABCA8 ABCC5 ABCG1 ABCA6 ABCA5	5.41e-08	49	309	9	GO:0140359
GeneOntologyMolecularFunction	ATP-dependent activity	ERCC2 ABCB7 ABCF1 ABCA4 ABCA13 PSMC4 ABCA9 ABCA8 KIF2B ATP11C HFM1 DHX29 DDX11L8 DDX4 KIF11 RAD51B KIF13B IPO8 DDX60 SMCHD1 SMARCAL1 ABCC5 MSH4 KIF20B ABCG1 ABCA6 ABCA5 TOP2B	3.69e-07	614	309	28	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	ERCC2 ABCB7 ABCF1 ABCA4 ABCA13 PSMC4 ABCA9 ABCA8 KIF2B ATP11C HFM1 DHX29 DDX11L8 DDX4 RAD51B KIF13B DDX60 SMCHD1 ABCC5 KIF20B ABCG1 ABCA6 ABCA5	4.33e-07	441	309	23	GO:0016887
GeneOntologyMolecularFunction	enzyme regulator activity	RIN3 TBC1D9B PPP1R12A CD109 ADGRB3 DENND1C TNFRSF10D ADGRV1 TBC1D8B ELFN2 RHOU TBC1D24 MALT1 BNIP2 NOD1 MGAT5 NF1 SERPINB4 SERPINB12 DENND4B A2ML1 EIF2B5 C3 PARP9 PREX1 VAV1 ROCK2 COL6A3 RASA1 KALRN CIP2A RCVRN RGS3 PREX2 PPP2R1B VAC14 FRY THADA PTPA P2RX7 EGFR DEPDC5 CTSH EIF2AK2 ELP4 SPATA13 PLCE1	5.89e-07	1418	309	47	GO:0030234
GeneOntologyMolecularFunction	lipid transporter activity	ABCA4 ABCA13 CEACAM6 ABCA9 ABCA8 CEACAM1 CLPTM1L ATP11C ATG9A APOB ABCG1 ABCA6 ABCA5 APOL3	2.38e-06	196	309	14	GO:0005319
GeneOntologyMolecularFunction	transporter activity	TRPM6 SLC43A2 ABCB7 ABCA4 ASIC2 ABCA13 TRPC6 PKD1L1 SLC22A15 CEACAM6 KCNIP3 TMC3 ABCA9 ABCA8 RYR2 CHRNB3 RYR3 CEACAM1 CLPTM1L SLC13A4 KCNK2 ATP11C ATG9A CACNA1C CACNA1S TPCN2 IPO8 ABCC5 APOB SLC7A7 CNNM4 ABCG1 SLC8A3 SLC9A5 P2RX7 ABCA6 ABCA5 SLC25A1 APOL3 OTOP1 GSDMA MFSD5	3.89e-06	1289	309	42	GO:0005215
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCB7 ABCA4 ABCA13 ABCA9 ABCA8 IPO8 ABCC5 ABCG1 ABCA6 ABCA5	7.51e-06	109	309	10	GO:0042626
GeneOntologyMolecularFunction	transmembrane transporter activity	TRPM6 SLC43A2 ABCB7 ABCA4 ASIC2 ABCA13 TRPC6 PKD1L1 SLC22A15 CEACAM6 KCNIP3 TMC3 ABCA9 ABCA8 RYR2 CHRNB3 RYR3 CEACAM1 SLC13A4 KCNK2 CACNA1C CACNA1S TPCN2 IPO8 ABCC5 SLC7A7 CNNM4 ABCG1 SLC8A3 SLC9A5 P2RX7 ABCA6 ABCA5 SLC25A1 APOL3 OTOP1 GSDMA MFSD5	1.53e-05	1180	309	38	GO:0022857
GeneOntologyMolecularFunction	pyrophosphatase activity	ERCC2 ABCB7 ABCF1 ABCA4 ABCA13 PSMC4 ACYP1 ABCA9 ABCA8 RHOU KIF2B CANT1 ATP11C HFM1 DHX29 DDX11L8 DDX4 RAD51B KIF13B RASA1 DDX60 SMCHD1 ABCC5 RGS3 KIF20B ABCG1 ABCA6 ABCA5 MX2	4.85e-05	839	309	29	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	ERCC2 ABCB7 ABCF1 ABCA4 ABCA13 PSMC4 ACYP1 ABCA9 ABCA8 RHOU KIF2B CANT1 ATP11C HFM1 DHX29 DDX11L8 DDX4 RAD51B KIF13B RASA1 DDX60 SMCHD1 ABCC5 RGS3 KIF20B ABCG1 ABCA6 ABCA5 MX2	4.95e-05	840	309	29	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	ERCC2 ABCB7 ABCF1 ABCA4 ABCA13 PSMC4 ACYP1 ABCA9 ABCA8 RHOU KIF2B CANT1 ATP11C HFM1 DHX29 DDX11L8 DDX4 RAD51B KIF13B RASA1 DDX60 SMCHD1 ABCC5 RGS3 KIF20B ABCG1 ABCA6 ABCA5 MX2	4.95e-05	840	309	29	GO:0016818
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	ERCC2 ABCB7 ABCF1 ABCA4 ABCA13 PSMC4 ABCA9 ABCA8 RHOU KIF2B ATP11C HFM1 DHX29 DDX11L8 DDX4 RAD51B KIF13B RASA1 DDX60 SMCHD1 ABCC5 RGS3 KIF20B ABCG1 ABCA6 ABCA5 MX2	7.80e-05	775	309	27	GO:0017111
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RIN3 TBC1D9B ADGRB3 DENND1C TBC1D8B RHOU TBC1D24 BNIP2 NF1 DENND4B EIF2B5 PREX1 VAV1 RASA1 KALRN RGS3 PREX2 DEPDC5 SPATA13 PLCE1	1.35e-04	507	309	20	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RIN3 TBC1D9B ADGRB3 DENND1C TBC1D8B RHOU TBC1D24 BNIP2 NF1 DENND4B EIF2B5 PREX1 VAV1 RASA1 KALRN RGS3 PREX2 DEPDC5 SPATA13 PLCE1	1.35e-04	507	309	20	GO:0030695
GeneOntologyMolecularFunction	phosphotransferase activity, for other substituted phosphate groups	PTDSS1 CEPT1 FKTN PGS1	3.30e-04	22	309	4	GO:0016780
GeneOntologyMolecularFunction	primary active transmembrane transporter activity	ABCB7 ABCA4 ABCA13 ABCA9 ABCA8 IPO8 ABCC5 ABCG1 ABCA6 ABCA5	4.70e-04	178	309	10	GO:0015399
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	TRPM6 TRPC6 PKD1L1 RYR2 RYR3 CACNA1C CACNA1S TPCN2 SLC8A3	5.87e-04	151	309	9	GO:0015085
GeneOntologyMolecularFunction	enzyme activator activity	RIN3 TBC1D9B ADGRB3 TNFRSF10D TBC1D8B TBC1D24 MALT1 BNIP2 NOD1 NF1 PREX1 ROCK2 RASA1 RCVRN RGS3 PREX2 VAC14 PTPA P2RX7 EGFR DEPDC5 CTSH	6.02e-04	656	309	22	GO:0008047
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	ERCC2 MGMT HFM1 DNASE1L2 DDX11L8 RAD51B RAG1 POLE SMARCAL1 MSH4 XRCC1 TOP2B	8.30e-04	262	309	12	GO:0140097
GeneOntologyMolecularFunction	calcium channel activity	TRPM6 TRPC6 PKD1L1 RYR2 RYR3 CACNA1C CACNA1S TPCN2	9.08e-04	129	309	8	GO:0005262
GeneOntologyMolecularFunction	monoatomic cation channel activity	TRPM6 ASIC2 TRPC6 PKD1L1 KCNIP3 RYR2 CHRNB3 RYR3 KCNK2 CACNA1C CACNA1S TPCN2 P2RX7 OTOP1	9.73e-04	343	309	14	GO:0005261
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	RIN3 DENND1C RHOU DENND4B EIF2B5 PREX1 VAV1 KALRN PREX2 SPATA13 PLCE1	9.89e-04	231	309	11	GO:0005085
GeneOntologyMolecularFunction	intramembrane lipid transporter activity	ABCA4 CLPTM1L ATP11C ATG9A ABCG1	1.13e-03	51	309	5	GO:0140303
GeneOntologyCellularComponent	nuclear envelope	ABCF1 ACHE PTGER4 GTF3C3 RYR2 CEPT1 BNIP2 DST KPNA1 IPO8 RASA1 RTCB SYNE1 AKR7A2 RIF1 P2RX7 EGFR MTOR ANKRD17 PRKG2 MX2	8.61e-05	560	306	21	GO:0005635
GeneOntologyCellularComponent	I band	PPP1R12A ACTN3 RYR2 RYR3 DST CACNA1C CACNA1S ANK1 FHOD3 MTM1	1.74e-04	166	306	10	GO:0031674
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO2 NOMO1 NOMO3	2.44e-04	9	306	3	GO:0160064
GeneOntologyCellularComponent	sarcomere	PPP1R12A ACTN3 RYR2 RYR3 DST CACNA1C CACNA1S ANK1 SYNE1 FHOD3 MTM1 MYOM2	3.24e-04	249	306	12	GO:0030017
Domain	ABC_TRANSPORTER_2	ABCB7 ABCF1 ABCA4 ABCA13 ABCA9 ABCA8 ABCC5 ABCG1 ABCA6 ABCA5	4.40e-09	48	305	10	PS50893
Domain	ABC_tran	ABCB7 ABCF1 ABCA4 ABCA13 ABCA9 ABCA8 ABCC5 ABCG1 ABCA6 ABCA5	4.40e-09	48	305	10	PF00005
Domain	ABC_TRANSPORTER_1	ABCB7 ABCF1 ABCA4 ABCA13 ABCA9 ABCA8 ABCC5 ABCG1 ABCA6 ABCA5	5.45e-09	49	305	10	PS00211
Domain	ABC_transporter-like	ABCB7 ABCF1 ABCA4 ABCA13 ABCA9 ABCA8 ABCC5 ABCG1 ABCA6 ABCA5	6.71e-09	50	305	10	IPR003439
Domain	ABC_A	ABCA4 ABCA13 ABCA9 ABCA8 ABCA6 ABCA5	1.54e-08	12	305	6	IPR026082
Domain	ARM-type_fold	CEP104 CAND2 CKAP5 LYST RYR3 NOP9 URB1 NF1 EIF2B5 KPNA1 NCAPD3 IPO8 CIP2A FHOD3 APOB PPP2R1B RIF1 VAC14 THADA ELMO3 MTOR FHOD1	4.44e-08	339	305	22	IPR016024
Domain	AAA+_ATPase	ABCB7 ABCF1 ABCA4 ABCA13 PSMC4 ABCA9 ABCA8 RAD51B ABCC5 ABCG1 ABCA6 ABCA5	4.40e-06	144	305	12	IPR003593
Domain	AAA	ABCB7 ABCF1 ABCA4 ABCA13 PSMC4 ABCA9 ABCA8 RAD51B ABCC5 ABCG1 ABCA6 ABCA5	4.40e-06	144	305	12	SM00382
Domain	ARM-like	CEP104 CAND2 CKAP5 NOP9 NF1 KPNA1 NCAPD3 IPO8 CIP2A FHOD3 PPP2R1B RIF1 VAC14 ELMO3 MTOR FHOD1	1.01e-05	270	305	16	IPR011989
Domain	DUF2012	NOMO2 NOMO1 NOMO3	1.70e-05	4	305	3	PF09430
Domain	DUF2012	NOMO2 NOMO1 NOMO3	1.70e-05	4	305	3	IPR019008
Domain	-	CEP104 CAND2 CKAP5 NOP9 NF1 KPNA1 NCAPD3 IPO8 CIP2A PPP2R1B RIF1 VAC14 MTOR FHOD1	1.81e-05	222	305	14	1.25.10.10
Domain	P-loop_NTPase	MAGI1 ERCC2 ABCB7 ABCF1 ABCA4 ABCA13 PSMC4 ABCA9 ABCA8 RHOU NOD1 LRRIQ1 KIF2B HFM1 DHX29 DDX4 KIF11 RAD51B KIF13B DDX60 SMARCAL1 IFI44 ABCC5 MSH4 KIF20B ABCG1 ABCA6 ABCA5 DYNC2LI1 ELP4 MX2	2.48e-05	848	305	31	IPR027417
Domain	HEAT	CEP104 CAND2 CKAP5 NCAPD3 PPP2R1B VAC14 MTOR	4.26e-05	58	305	7	IPR000357
Domain	ABC_transporter_CS	ABCB7 ABCF1 ABCA4 ABCC5 ABCG1 ABCA5	5.77e-05	42	305	6	IPR017871
Domain	-	TDRD15 TDRD6 RNF17	8.32e-05	6	305	3	2.40.50.90
Domain	Staphylococal_nuclease_OB-fold	TDRD15 TDRD6 RNF17	8.32e-05	6	305	3	IPR016071
Domain	HEAT	CEP104 CAND2 CKAP5 NCAPD3 PPP2R1B VAC14	1.24e-04	48	305	6	PF02985
Domain	HEAT_REPEAT	CEP104 CAND2 CKAP5 NCAPD3 PPP2R1B VAC14 MTOR	1.44e-04	70	305	7	PS50077
Domain	MacrogloblnA2_thiol-ester-bond	CD109 A2ML1 C3	2.27e-04	8	305	3	IPR019565
Domain	Carb-bd-like_fold	NOMO2 NOMO1 NOMO3	2.27e-04	8	305	3	IPR013784
Domain	Thiol-ester_cl	CD109 A2ML1 C3	2.27e-04	8	305	3	PF10569
Domain	A2M_N_2	CD109 A2ML1 C3	2.27e-04	8	305	3	SM01359
Domain	A2M_recep	CD109 A2ML1 C3	2.27e-04	8	305	3	SM01361
Domain	A2M	CD109 A2ML1 C3	2.27e-04	8	305	3	SM01360
Domain	MacrogloblnA2_CS	CD109 A2ML1 C3	2.27e-04	8	305	3	IPR019742
Domain	-	CD109 A2ML1 C3	2.27e-04	8	305	3	2.60.40.690
Domain	A2M	CD109 A2ML1 C3	4.75e-04	10	305	3	PF00207
Domain	A2M_N_2	CD109 A2ML1 C3	4.75e-04	10	305	3	IPR011625
Domain	A2M_comp	CD109 A2ML1 C3	4.75e-04	10	305	3	IPR011626
Domain	A2M_recep	CD109 A2ML1 C3	4.75e-04	10	305	3	PF07677
Domain	A2M_comp	CD109 A2ML1 C3	4.75e-04	10	305	3	PF07678
Domain	A2M_N_2	CD109 A2ML1 C3	4.75e-04	10	305	3	PF07703
Domain	A2M_N	CD109 A2ML1 C3	4.75e-04	10	305	3	PF01835
Domain	A2M_N	CD109 A2ML1 C3	4.75e-04	10	305	3	IPR002890
Domain	A-macroglobulin_rcpt-bd	CD109 A2ML1 C3	4.75e-04	10	305	3	IPR009048
Domain	ALPHA_2_MACROGLOBULIN	CD109 A2ML1 C3	4.75e-04	10	305	3	PS00477
Domain	Macroglobln_a2	CD109 A2ML1 C3	4.75e-04	10	305	3	IPR001599
Domain	Spectrin	ACTN3 DST KALRN SYNE1	4.83e-04	23	305	4	PF00435
Domain	Pkinase	RPS6KA5 DAPK2 PRAG1 CLK1 EIF2AK3 ROCK2 NPR2 KALRN CAMK4 GRK4 GUCY2C PRKCB PRKG2 MAPK4 CSNK2A3 EIF2AK2	5.63e-04	381	305	16	PF00069
Domain	-	ERCC2 ABCB7 ABCF1 ABCA4 ABCA13 PSMC4 ABCA9 ABCA8 RHOU NOD1 HFM1 DHX29 DDX4 RAD51B DDX60 SMARCAL1 IFI44 ABCC5 MSH4 ABCG1 ABCA6 ABCA5 DYNC2LI1 ELP4 MX2	5.69e-04	746	305	25	3.40.50.300
Domain	Kinase-like_dom	TRPM6 RPS6KA5 DAPK2 PRAG1 DST CLK1 EIF2AK3 ROCK2 NPR2 KALRN CAMK4 GRK4 EGFR GUCY2C MTOR PRKCB PRKG2 MAPK4 CSNK2A3 EIF2AK2	6.30e-04	542	305	20	IPR011009
Domain	RyR	RYR2 RYR3	7.89e-04	3	305	2	PF02026
Domain	RR_TM4-6	RYR2 RYR3	7.89e-04	3	305	2	PF06459
Domain	Ryan_recept	RYR2 RYR3	7.89e-04	3	305	2	IPR013333
Domain	Ryanodine_rcpt	RYR2 RYR3	7.89e-04	3	305	2	IPR003032
Domain	Ryanrecept_TM4-6	RYR2 RYR3	7.89e-04	3	305	2	IPR009460
Domain	-	CD109 A2ML1 C3	8.50e-04	12	305	3	1.50.10.20
Domain	C8	FCGBP MUC5B MUC6	8.50e-04	12	305	3	PF08742
Domain	TIL	FCGBP MUC5B MUC6	8.50e-04	12	305	3	PF01826
Domain	CarboxyPept_regulatory_dom	NOMO2 NOMO1 NOMO3	1.09e-03	13	305	3	IPR014766
Domain	C8	FCGBP MUC5B MUC6	1.09e-03	13	305	3	SM00832
Domain	Recoverin	KCNIP3 HPCAL4 RCVRN	1.09e-03	13	305	3	IPR028846
Domain	Unchr_dom_Cys-rich	FCGBP MUC5B MUC6	1.09e-03	13	305	3	IPR014853
Domain	-	NOMO2 NOMO1 NOMO3	1.09e-03	13	305	3	2.60.40.1120
Domain	Spectrin_repeat	ACTN3 DST KALRN SYNE1	1.20e-03	29	305	4	IPR002017
Domain	TIL_dom	FCGBP MUC5B MUC6	1.37e-03	14	305	3	IPR002919
Domain	TUDOR	TDRD15 TDRD6 RNF17	1.37e-03	14	305	3	PF00567
Domain	Pyridine_nuc-diS_OxRdtase_2	AIFM3 DPYD	1.56e-03	4	305	2	IPR000103
Domain	VDCC_L_a1su	CACNA1C CACNA1S	1.56e-03	4	305	2	IPR005446
Domain	3HCDH	HADHA HADH	1.56e-03	4	305	2	PF00725
Domain	3-OHacyl-CoA_DH_NAD-bd	HADHA HADH	1.56e-03	4	305	2	IPR006176
Domain	3-OHacyl-CoA_DH_CS	HADHA HADH	1.56e-03	4	305	2	IPR006180
Domain	3HC_DH_C	HADHA HADH	1.56e-03	4	305	2	IPR006108
Domain	3HCDH	HADHA HADH	1.56e-03	4	305	2	PS00067
Domain	3HCDH_N	HADHA HADH	1.56e-03	4	305	2	PF02737
Domain	CAP	CLEC18A CLEC18B CLEC18C	1.70e-03	15	305	3	PF00188
Domain	FH2	FMN1 FHOD3 FHOD1	1.70e-03	15	305	3	PS51444
Domain	SCP	CLEC18A CLEC18B CLEC18C	1.70e-03	15	305	3	SM00198
Domain	-	CLEC18A CLEC18B CLEC18C	1.70e-03	15	305	3	3.40.33.10
Domain	FH2	FMN1 FHOD3 FHOD1	1.70e-03	15	305	3	SM00498
Domain	Allrgn_V5/Tpx1	CLEC18A CLEC18B CLEC18C	1.70e-03	15	305	3	IPR001283
Domain	FH2_Formin	FMN1 FHOD3 FHOD1	1.70e-03	15	305	3	IPR015425
Domain	FH2	FMN1 FHOD3 FHOD1	1.70e-03	15	305	3	PF02181
Domain	CAP_domain	CLEC18A CLEC18B CLEC18C	1.70e-03	15	305	3	IPR014044
Domain	SPEC	ACTN3 DST KALRN SYNE1	1.75e-03	32	305	4	SM00150
Domain	Spectrin/alpha-actinin	ACTN3 DST KALRN SYNE1	1.75e-03	32	305	4	IPR018159
Domain	PH_dom-like	ANKS1B LYST PARP9 PLD2 PREX1 VAV1 ROCK2 RASA1 KALRN PLEKHD1 RGS3 PREX2 ELMO3 MTM1 SPATA13 PLCE1	1.81e-03	426	305	16	IPR011993
Domain	GRAM	TBC1D9B TBC1D8B MTM1	2.06e-03	16	305	3	SM00568
Domain	VWF_type-D	FCGBP MUC5B MUC6	2.06e-03	16	305	3	IPR001846
Domain	VWFD	FCGBP MUC5B MUC6	2.06e-03	16	305	3	PS51233
Domain	VWD	FCGBP MUC5B MUC6	2.06e-03	16	305	3	SM00216
Domain	VWD	FCGBP MUC5B MUC6	2.06e-03	16	305	3	PF00094
Domain	AGC-kinase_C	RPS6KA5 ROCK2 GRK4 PRKCB PRKG2	2.17e-03	56	305	5	IPR000961
Domain	S_TK_X	RPS6KA5 ROCK2 GRK4 PRKCB PRKG2	2.17e-03	56	305	5	SM00133
Domain	AGC_KINASE_CTER	RPS6KA5 ROCK2 GRK4 PRKCB PRKG2	2.17e-03	56	305	5	PS51285
Pathway	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	ABCB7 ABCF1 ABCA4 PSMA2 PSMA5 PSMC4 PSMD10 ABCA9 ABCA8 ABCC5 ABCG1 ABCA6 ABCA5	1.30e-08	99	241	13	MM14986
Pathway	REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	ABCB7 ABCF1 ABCA4 PSMA2 PSMA5 PSMC4 PSMD10 ABCA9 ABCA8 ABCC5 ABCG1 ABCA6 ABCA5	2.11e-08	103	241	13	M758
Pathway	KEGG_ABC_TRANSPORTERS	ABCB7 ABCA4 ABCA13 ABCA9 ABCA8 ABCC5 ABCG1 ABCA6 ABCA5	4.52e-08	44	241	9	M11911
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	TRPM6 SLC43A2 ABCB7 ABCF1 ABCA4 ASIC2 PSMA2 PSMA5 TRPC6 SLC22A15 PSMC4 PSMD10 ABCA9 ABCA8 RYR2 RYR3 SLC13A4 ATP11C TPCN2 STEAP4 ABCC5 APOB SLC7A7 ABCG1 SLC8A3 SLC9A5 ABCA6 ABCA5 SLC25A1	5.43e-06	681	241	29	MM14985
Pathway	REACTOME_TRANSPORT_OF_SMALL_MOLECULES	TRPM6 SLC43A2 ABCB7 ABCF1 ABCA4 ASIC2 PSMA2 PSMA5 TRPC6 SLC22A15 PSMC4 PSMD10 ABCA9 ABCA8 RYR2 RYR3 SLC13A4 ATP11C TPCN2 STEAP4 ABCC5 APOB SLC7A7 ABCG1 SLC8A3 SLC9A5 ABCA6 ABCA5 SLC25A1	2.35e-05	736	241	29	M27287
Pathway	KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY	RYR2 RYR3 CACNA1C CACNA1S	2.50e-05	11	241	4	M47958
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ABCF1 PSMA2 PSMA5 WDR46 CKAP5 PSMC4 MCCC1 DPM1 GTF3C3 URB1 NF1 DST WDR75 H4C1 SERPINB4 SERPINB12 NFKB2 GLS A2ML1 EIF3L EIF2B5 MACROH2A2 DHX29 ANKRD52 CCDC93 KIF11 KPNA1 RTCB POLE SMCHD1 NAA50 TBL3 KIF20B RIF1 MICAL2 SLC25A1 FHOD1 ASS1 SUPT16H ANKRD17 GSDMA HADHA EIF2AK2 TOP2B	1.68e-13	1353	312	44	29467282
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	TRPM6 ABCF1 PSMA5 WDR46 CKAP5 PSMC4 DPM1 GTF3C3 FANCD2 JARID2 CLPTM1L NOP9 URB1 NF1 WDR75 H4C1 SERPINB12 GLS EIF3L EIF2B5 ALDH2 TDRD6 MMP9 DHX29 KIF11 NCAPD3 IPO8 RTCB HSDL2 SYNE1 POLE SMCHD1 APOB TBL3 NOMO1 RIF1 THADA MTOR SUPT16H HADHA FUS EIF2AK2 TOP2B	3.85e-12	1425	312	43	30948266
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ABCA4 RYR2 FER1L6 CLPTM1L NF1 WDR75 GLS HFM1 MACROH2A2 ANKRD52 PREX1 LRRC41 KPNA1 AMPD1 NCAPD3 HSDL2 POLE SMARCAL1 BABAM2 PREPL TBL3 AKR7A2 APOL3 OTOP1 ANKRD17 NOMO3	1.92e-10	638	312	26	31182584
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CEP104 PPP1R12A PSMA2 ASH1L ANKS1B ACTN3 LYST MECP2 RYR2 CHRNB3 FER1L6 DST WDR75 H4C1 GLS ATP11C ALDH2 TASOR PREX1 KIF11 RAD51B ROCK2 KIF13B CACNA1C SYNE1 SMCHD1 ABCC5 APOB RNF17 SHANK2 TIMM21 SLC25A1 SUPT16H PLXNA4 UGGT2 MYOM2 HADHA FUS TOP2B SPATA13	2.85e-10	1442	312	40	35575683
Pubmed	Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database.	ABCB7 ABCF1 ABCA4 ABCA9 ABCC5 ABCA6 ABCA5	6.64e-10	22	312	7	8894702
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	CAND2 PSMA2 PSMA5 CD109 CKAP5 PSMC4 PSMD10 FANCD2 C3 PLD2 DHX29 ANKRD52 KIF11 KPNA1 ROCK2 NCAPD3 IPO8 RTCB CIP2A POLE SMCHD1 DUSP6 PREPL NOMO1 CNNM4 PPP2R1B MTOR MTM1 ANKRD17 CDC25B	5.52e-09	974	312	30	28675297
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	ERCC2 ABCF1 CAND2 WDR46 PSMC4 DPM1 FANCD2 NOP9 EIF3L DHX29 KIF11 KPNA1 KIF13B NCAPD3 RTCB POLE PPP4C TIMM21 MTOR SLC25A1 SUPT16H ANKRD17 HADHA EIF2AK2 TOP2B	7.00e-09	704	312	25	29955894
Pubmed	Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.	ERCC2 ALDH1L1 FANCA MGMT NINJ1 ALDH2 VDR RAG1 APOB XRCC1 P2RX7 ABCA6 EGFR ABCA5 HADHA CDC25B CTSH CXCR2	1.44e-08	382	312	18	19170196
Pubmed	Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes.	ABCA9 ABCA8 ABCA6 ABCA5	3.15e-08	5	312	4	12532264
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	ERCC2 CAND2 PSMA2 PSMA5 PSMD10 FANCD2 CEPT1 WDR75 NOMO2 EXOC7 ANKRD52 LRRC41 KPNA1 NCAPD3 IPO8 CIP2A POLE NOMO1 RIF1 MTOR TMLHE NOMO3	3.93e-08	606	312	22	36538041
Pubmed	Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus.	ABCB7 ABCF1 ABCA8 IPO8 ABCC5 ABCG1	4.41e-08	23	312	6	10708515
Pubmed	PTEN identified as important risk factor of chronic obstructive pulmonary disease.	ERCC2 ALDH1L1 FANCA MGMT NINJ1 ALDH2 VDR RAG1 APOB XRCC1 P2RX7 ABCA6 EGFR ABCA5 HADHA CDC25B CTSH	6.13e-08	374	312	17	19625176
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	TBC1D9B ABCB7 CAND2 PSMA2 PSMA5 CD109 PSMC4 MCCC1 DPM1 FANCD2 CLPTM1L NOP9 URB1 DST NFKB2 EIF3L EIF2B5 ALDH2 EXOC7 DHX29 CCDC93 NCAPD3 IPO8 RTCB DDX60 CIP2A XRCC1 CNNM4 PPP2R1B THADA PPP4C MTOR SUPT16H HADHA TOP2B	1.06e-07	1440	312	35	30833792
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MAGI1 ABCF1 CAND2 PPP1R12A PSMA2 TTC21A PTDSS1 PSMC4 NF1 EML5 EIF3L PTPRQ EIF2B5 WDR35 C3 EXOC7 CCDC93 ROCK2 KIF13B ATG16L1 IPO8 RTCB HSDL2 CIP2A NOMO1 CNNM4 RIF1 THADA MTOR SUPT16H UGGT2 PRKG2 CDC25B	1.36e-07	1321	312	33	27173435
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	ERCC2 ABCB7 CAND2 PSMA2 PSMA5 PTDSS1 PSMC4 PSMD10 DPM1 GTF3C3 URB1 CEPT1 WDR75 H4C1 NOMO2 LRRC41 KPNA1 NCAPD3 RTCB HSDL2 POLE TBL3 NOMO1 PPP2R1B RIF1 PPP4C TIMM21 SLC25A1 NUB1 HADHA FUS NOMO3	1.40e-07	1257	312	32	37317656
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	ABCF1 PPP1R12A CD109 CKAP5 MECP2 DPM1 GTF3C3 DST WDR75 H4C1 SERPINB12 GLS EIF3L C3 KIF11 KPNA1 RTCB DDX60 SMCHD1 TBL3 KIF20B THOC5 EGFR SLC25A1 FHOD1 ASS1 SUPT16H ANKRD17 GSDMA HADHA FUS EIF2AK2	1.40e-07	1257	312	32	36526897
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	TBC1D9B CAND2 PSMC4 DPM1 GTF3C3 FANCA FANCD2 URB1 EIF3L EIF2B5 EXOC7 KIF11 NCAPD3 HSDL2 CIP2A POLE TBL3 CNNM4 VAC14 THADA TIMM21 MTOR SLC25A1 ANKRD17 UGGT2 HADHA NOMO3	1.41e-07	942	312	27	31073040
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	B3GALNT1 ABCB7 ABCF1 CD109 PTDSS1 EXTL2 GTF3C3 FANCA CLPTM1L MGAT5 NF1 CANT1 NOMO2 FKTN EIF2AK3 ROCK2 NCAPD3 SLITRK4 RUFY1 DEGS1 NOMO1 VAC14 THADA EGFR MICAL2 FHOD1 UGGT2 BSCL2 OSMR EIF2AK2 MFSD5	1.64e-07	1201	312	31	35696571
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	ERCC2 ABCB7 PPP1R12A CD109 PTDSS1 PSMC4 CLPTM1L DST WDR75 NOMO2 GLS EIF3L C3 ATG9A KIF11 ROCK2 RTCB SMCHD1 APOB BABAM2 TBL3 AKR7A2 GDA PTPA EGFR ASS1 HACL1 UGGT2 BSCL2 HADHA FUS EIF2AK2	2.80e-07	1297	312	32	33545068
Pubmed	Genetic susceptibility to distinct bladder cancer subphenotypes.	ERCC2 ALDH1L1 FANCA MGMT NINJ1 ALDH2 VDR RAG1 APOB XRCC1 P2RX7 ABCA6 EGFR ABCA5 HADHA CDC25B CTSH	3.27e-07	421	312	17	19692168
Pubmed	Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.	ERCC2 ALDH1L1 FANCA MGMT NINJ1 ALDH2 VDR RAG1 XRCC1 P2RX7 ABCA6 EGFR ABCA5 HADHA CDC25B CTSH	4.35e-07	381	312	16	18676680
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	PSMA5 CKAP5 PSMC4 DPM1 GTF3C3 BPNT1 EIF3L ALDH2 KPNA1 RTCB HSDL2 SMCHD1 TBL3 AKR7A2 SLC25A1 ANKRD17 HADHA HADH NOMO3	4.58e-07	534	312	19	35032548
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	ABCF1 CKAP5 DPM1 GTF3C3 NOP9 URB1 EIF2B5 MACROH2A2 EXOC7 TASOR DHX29 NCAPD3 IPO8 RTCB POLE SMCHD1 XRCC1 TBL3 KIF20B RIF1 SUPT16H EIF2AK2 TOP2B	4.75e-07	759	312	23	35915203
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ABCB7 ABCF1 CAND2 PTDSS1 PSMC4 GTF3C3 CLPTM1L URB1 WDR75 NOMO2 GLS PDZD8 ALDH2 DHX29 ANKRD52 EIF2AK3 LRRC41 IPO8 HSDL2 SYNE1 CIP2A POLE PREPL TBL3 DEGS1 THOC5 NOMO1 THADA TIMM21 EGFR SUPT16H UGGT2 HADHA TOP2B	6.62e-07	1487	312	34	33957083
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	ABCF1 PPP1R12A CD109 PSMC4 DST WDR75 H4C1 MACROH2A2 PLD2 KPNA1 RTCB SMCHD1 XRCC1 TBL3 THOC5 EGFR SUPT16H HADHA FUS EIF2AK2 TOP2B	6.97e-07	660	312	21	32780723
Pubmed	Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity.	CLEC18A CLEC18B CLEC18C	7.15e-07	3	312	3	26170455
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO2 NOMO1 NOMO3	7.15e-07	3	312	3	36011023
Pubmed	Defining the roles of human carcinoembryonic antigen-related cellular adhesion molecules during neutrophil responses to Neisseria gonorrhoeae.	CEACAM3 CEACAM6 CEACAM1	7.15e-07	3	312	3	22064717
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO2 NOMO1 NOMO3	7.15e-07	3	312	3	25576386
Pubmed	Antibody ligation of CEACAM1, CEACAM3, and CEACAM6, differentially enhance the cytokine release of human neutrophils in responses to Candida albicans.	CEACAM3 CEACAM6 CEACAM1	7.15e-07	3	312	3	34847408
Pubmed	Selected DNA repair polymorphisms and gastric cancer in Poland.	ERCC2 MGMT XRCC1	7.15e-07	3	312	3	15802298
Pubmed	The C-type lectin-like domain superfamily.	CLEC18A CLEC18B CLEC18C	7.15e-07	3	312	3	16336259
Pubmed	Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection.	CLEC18A CLEC18B CLEC18C	7.15e-07	3	312	3	33603190
Pubmed	Effects of ALDH2 gene polymorphisms and alcohol-drinking behavior on micronuclei frequency in non-smokers.	ERCC2 ALDH2 XRCC1	7.15e-07	3	312	3	14568296
Pubmed	Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin.	KCNIP3 RYR2 RYR3	7.15e-07	3	312	3	29730765
Pubmed	Influence of polymorphisms in DNA repair genes XPD, XRCC1 and MGMT on DNA damage induced by gamma radiation and its repair in lymphocytes in vitro.	ERCC2 MGMT XRCC1	7.15e-07	3	312	3	16038584
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ABCF1 PPP1R12A PSMC4 ALDH1L1 DPM1 RYR3 KIF2B CACNA1C DPYD ANK1 SLITRK4 RUFY1 LOXHD1 PPP4C LGI2 ASS1 MYOM2 CSNK2A3	7.15e-07	497	312	18	36774506
Pubmed	L-type voltage-dependent calcium channel alpha subunit 1C is a novel candidate gene associated with secondary hyperparathyroidism: an application of haplotype-based analysis for multiple linked single nucleotide polymorphisms.	RYR2 RYR3 VDR CACNA1C CACNA1S GRK4 CCKAR P2RX7 EGFR OSMR	7.29e-07	143	312	10	20424473
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MAGI1 PPP1R12A CKAP5 ADGRB3 ANKS1B NF1 DST FBXO41 KIF11 KPNA1 ROCK2 KIF13B KALRN SYNE1 PREPL GDA FRY SHANK2 P2RX7 MTOR SH3D19 SUPT16H ANKRD17 PRKCB FUS SPATA13	7.48e-07	963	312	26	28671696
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	KREMEN1 ABCA13 CEACAM6 LYST PEBP4 A2ML1 ATP11C PGS1 IPO8 KALRN SMCHD1 DUSP6 ABCC5 PLEKHD1 LOXHD1 SHANK2 GUCY2C ZFHX2 NOMO3	7.51e-07	552	312	19	10737800
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	B3GALNT1 PSMA2 CKAP5 BPNT1 SERPINB12 EIF3L KPNA1 KALRN VAC14 EGFR MTOR GSDMA NUB1 HADH	7.77e-07	304	312	14	32235678
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	TTC21A CKAP5 HIC2 ITGAE FANCA URB1 DST H4C1 DENND4B EIF3L ATG16L1 ANK1 PCDHB12 NTMT1 PCDHA5 FRY LOXHD1 PLXNA4 PRKCB HADHA ELP4 CXCR2	1.06e-06	736	312	22	29676528
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ABCB7 PPP1R12A PSMA5 CKAP5 HIC2 MECP2 GTF3C3 NOP9 NFIL3 NFKB2 A2ML1 MACROH2A2 ANKRD52 EIF2AK3 LRRC41 KPNA1 NCAPD3 POLE SMARCAL1 XRCC1 RIF1 ANKRD17 GSDMA TOP2B	1.07e-06	857	312	24	25609649
Pubmed	Large-scale concatenation cDNA sequencing.	RFK MALT1 MGAT5 NF1 PCDH11X DHX29 CCDC93 KPNA1 CACNA1C NCAPD3 RGS3 FAM135B RIF1 ABCG1 SHANK2 LGI2 MICAL2 BSCL2 EPAS1	1.15e-06	568	312	19	9110174
Pubmed	A "double adaptor" method for improved shotgun library construction.	RFK MALT1 MGAT5 NF1 PCDH11X DHX29 CCDC93 KPNA1 CACNA1C NCAPD3 RGS3 FAM135B RIF1 ABCG1 SHANK2 LGI2 MICAL2 BSCL2 EPAS1	1.34e-06	574	312	19	8619474
Pubmed	Association study between single-nucleotide polymorphisms in 199 drug-related genes and commonly measured quantitative traits of 752 healthy Japanese subjects.	ABCB7 ABCF1 ABCA4 ALDH1L1 ABCA8 ALDH2 DPYD ABCC5 ABCG1 ABCA6 ABCA5	1.55e-06	193	312	11	19343046
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	TBC1D9B ABCB7 PPP1R12A PSMA2 PSMA5 PSMC4 ACTN3 DPM1 SERPINB12 EIF3L C3 EXOC7 IPO8 CIP2A PPP2R1B THADA EGFR MTOR GSDMA MX2	2.00e-06	647	312	20	26618866
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	WDR46 CKAP5 URB1 WDR75 MACROH2A2 TASOR DHX29 SYNE1 SMCHD1 TBL3 SUPT16H GSDMA EIF2AK2 TOP2B	2.19e-06	332	312	14	25693804
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	PTDSS1 CKAP5 CLPTM1L NCAPD3 DDX60 SMCHD1 EGFR MTOR SUPT16H ANKRD17 TOP2B	2.42e-06	202	312	11	33005030
Pubmed	Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.	ERCC2 FANCA FANCD2 MGMT RAD51B POLE XRCC1	2.65e-06	68	312	7	20496165
Pubmed	Defining the membrane proteome of NK cells.	KDM3A ABCF1 PTDSS1 CKAP5 PSMC4 DPM1 CLPTM1L NF1 MGMT H4C1 EIF3L PDZD8 PARP9 ATG9A EXOC7 EIF2AK3 KIF11 LRRC41 NCAPD3 HSDL2 NOMO1 MTOR FHOD1 APOL3 ANKRD17 ABHD13 EIF2AK2 MFSD5	2.80e-06	1168	312	28	19946888
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO2 NOMO1 NOMO3	2.84e-06	4	312	3	9267806
Pubmed	DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients.	ERCC2 MGMT XRCC1	2.84e-06	4	312	3	16369171
Pubmed	Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function.	FANCA FANCD2 ALDH2	2.84e-06	4	312	3	22922648
Pubmed	Reduced expression of human DNA repair genes in esophageal squamous-cell carcinoma in china.	ERCC2 MGMT XRCC1	2.84e-06	4	312	3	17479411
Pubmed	Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma.	ERCC2 MGMT XRCC1	2.84e-06	4	312	3	18386788
Pubmed	Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells.	CEACAM3 CEACAM6 CEACAM1	2.84e-06	4	312	3	19077207
Pubmed	Helicobacter pylori adhesin HopQ engages in a virulence-enhancing interaction with human CEACAMs.	CEACAM3 CEACAM6 CEACAM1	2.84e-06	4	312	3	27748768
Pubmed	Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA.	CEACAM3 CEACAM6 CEACAM1	2.84e-06	4	312	3	27748756
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO2 NOMO1 NOMO3	2.84e-06	4	312	3	31833031
Pubmed	Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis.	ERCC2 MGMT XRCC1	2.84e-06	4	312	3	16030112
Pubmed	Acute digoxin loading reduces ABCA8A mRNA expression in the mouse liver.	ABCA9 ABCA8 ABCA5	2.84e-06	4	312	3	16445568
Pubmed	The mannose receptor mediates uptake of soluble but not of cell-associated antigen for cross-presentation.	CLEC18A CLEC18B CLEC18C	2.84e-06	4	312	3	16709836
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	RIN3 ERCC2 TBC1D9B IPP PRAG1 LYST TBC1D24 FANCA URB1 DST CANT1 NFKB2 PDZD8 ATG9A PREX1 KALRN POLE ADGRL1 BABAM2 VAC14 THADA SHANK2 KLHL36 MTOR DEPDC5 MFSD5 SPATA13	2.99e-06	1105	312	27	35748872
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	ABCF1 GTF3C3 FANCD2 JARID2 PLD2 DHX29 KIF11 LRRC41 NCAPD3 IPO8 RTCB NAA50 KIF20B SUPT16H HADHA	3.54e-06	396	312	15	26687479
Pubmed	Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	TBC1D9B CAND2 ADGRV1 ROCK2 KIF13B SMCHD1 ANKRD17 DEPDC5	4.05e-06	102	312	8	9734811
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	MAGI1 PPP1R12A PSMA2 PSMC4 PSMD10 TNFRSF10D DPM1 GTF3C3 MALT1 SERPINB4 EIF3L EIF2B5 PREX1 KPNA1 ROCK2 ATG16L1 POLE XRCC1 BABAM2 DEGS1 CNNM4 VAC14 LOXHD1 PPP4C SLC25A1 HADHA FUS CDC25B EIF2AK2	5.82e-06	1284	312	29	17353931
Pubmed	DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese Health Study.	ERCC2 MGMT XRCC1	7.06e-06	5	312	3	18006925
Pubmed	Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand.	ERCC2 MGMT XRCC1	7.06e-06	5	312	3	16373199
Pubmed	Case-only study of interactions between DNA repair genes (hMLH1, APEX1, MGMT, XRCC1 and XPD) and low-frequency electromagnetic fields in childhood acute leukemia.	ERCC2 MGMT XRCC1	7.06e-06	5	312	3	19052983
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	NF1 CCDC93 NCAPD3 HSDL2 POLE SMARCAL1 RIF1 MTOR DEPDC5	7.82e-06	147	312	9	29576527
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ABCF1 DPM1 FANCA CLPTM1L NOP9 DST EIF2B5 EXOC7 TASOR DDX11L8 LRRC41 NCAPD3 PGS1 POLE RGS3 ANKRD17 UGGT2 CDC25B PLCE1	7.99e-06	650	312	19	38777146
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ABCF1 WDR46 CKAP5 GTF3C3 URB1 NF1 DST WDR75 EIF3L ANKRD52 RTCB POLE SMCHD1 TBL3 RIF1 MTOR ANKRD17 HADHA FUS	8.52e-06	653	312	19	22586326
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	PSMA5 PTDSS1 CKAP5 PSMC4 FANCD2 CLPTM1L CEPT1 NF1 EIF2B5 ATG9A EXOC7 IPO8 CIP2A NOMO1 RIF1 THADA MTOR SLC25A1 EIF2AK2	9.28e-06	657	312	19	36180527
Pubmed	Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran.	ERCC2 MGMT ALDH2 XRCC1	1.06e-05	16	312	4	19826048
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TBC1D9B PTDSS1 ELFN2 ABCA8 GLS WDR35 EXOC7 TASOR PREX1 ROCK2 KIF13B CIP2A THOC5 CNNM4 GDA THADA	1.18e-05	493	312	16	15368895
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MAGI1 PPP1R12A TTC21A ASH1L PTDSS1 ADGRV1 KCNIP3 MALT1 MACROH2A2 LRRC41 KPNA1 RAD51B CACNA1C TPCN2 RASA1 SH3BGR ADGRL1 BABAM2 CNNM4 PPP2R1B ABCG1 THADA PPP4C SHANK2 EGFR MICAL2 ASS1 ZFHX2 ANKRD17 ZFHX3 BSCL2	1.37e-05	1489	312	31	28611215
Pubmed	P-Rex and Vav Rac-GEFs in platelets control leukocyte recruitment to sites of inflammation.	PREX1 VAV1 PREX2	1.40e-05	6	312	3	25538043
Pubmed	Cloning, expression and genetic mapping of the mouse SH3 domain protein, SH3D2B.	C3 VAV1 EIF2AK2	1.40e-05	6	312	3	9434950
Pubmed	HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.	RYR2 RYR3 EIF2AK3	1.40e-05	6	312	3	19009018
Pubmed	Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.	ERCC2 XRCC1 EGFR	1.40e-05	6	312	3	20504250
Pubmed	MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity.	MAGEA2 PSMC4 PSMD10	1.40e-05	6	312	3	12525503
Pubmed	ER stress disrupts Ca2+-signaling complexes and Ca2+ regulation in secretory and muscle cells from PERK-knockout mice.	RYR2 EIF2AK3 CACNA1C	1.40e-05	6	312	3	16352659
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	ABCB7 PPP1R12A CKAP5 PSMC4 MCCC1 WDR75 NOMO2 GLS EIF2B5 ALDH2 EXOC7 KIF11 LRRC41 KPNA1 TBL3 THOC5 HADHA	1.49e-05	560	312	17	35241646
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	ABCB7 PSMA2 PSMA5 PSMC4 FANCD2 CLPTM1L CEPT1 DST WDR75 GLS PDZD8 ALDH2 EIF2AK3 DDX4 IPO8 HSDL2 SYNE1 CIP2A POLE NAA50 PREPL TBL3 THADA CLYBL TMLHE SH3D19 ASS1 SUPT16H HADHA HADH EIF2AK2	1.50e-05	1496	312	31	32877691
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ERCC2 ABCF1 PPP1R12A PTDSS1 CKAP5 MECP2 JARID2 CLPTM1L URB1 CEPT1 DST WDR75 EIF3L TASOR DHX29 PREX1 KPNA1 NCAPD3 RTCB SYNE1 XRCC1 BABAM2 TBL3 KIF20B NOMO1 RIF1 SHANK2 SLC25A1 ANKRD17 ZFHX3 EIF2AK2	1.52e-05	1497	312	31	31527615
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ABCF1 PPP1R12A TTC21A PTDSS1 CKAP5 ANKS1B ALDH1L1 ACTN3 ELFN2 MECP2 TBC1D24 NF1 DST EIF3L FBXO41 ALDH2 DHX29 ROCK2 RTCB KALRN SYNE1 ADGRL1 GDA SHANK2 MICAL2 PLXNA4 PRKCB HADHA HADH CPNE4	1.67e-05	1431	312	30	37142655
Pubmed	Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.	ERCC2 ALDH1L1 MGMT RAG1 XRCC1	1.69e-05	36	312	5	18830263
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	ABCF1 CAND2 PPP1R12A PSMA2 PSMA5 CKAP5 PSMC4 PSMD10 GTF3C3 DST LRRIQ1 H4C1 EIF3L EXOC7 KIF11 KPNA1 RTCB CIP2A PREPL AKR7A2 VAC14 SUPT16H ANKRD17 HADHA FUS EIF2AK2	1.74e-05	1149	312	26	35446349
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	PSMC4 GTF3C3 FANCA FANCD2 RAD51B NCAPD3 CIP2A POLE SMCHD1 BABAM2 KIF20B RIF1 TIMM21 SLC25A1 FUS	1.75e-05	453	312	15	29656893
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	ABCB7 PTDSS1 MCCC1 DPM1 BPNT1 CLPTM1L WDR75 CANT1 NOMO2 EIF3L PDZD8 ATP11C EIF2AK3 HSDL2 ABCC5 NAA50 DEGS1 NOMO1 CNNM4 SLC25A1 HADHA HADH NOMO3	1.97e-05	952	312	23	38569033
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	ERCC2 ALDH1L1 FANCA NOD1 MGMT MMP9 VDR RAG1 DPYD XRCC1 EGFR MTOR CXCR2	2.00e-05	351	312	13	20453000
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	TRPC6 RYR2 RYR3 CACNA1C SLC8A3	2.22e-05	38	312	5	30786075
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	TDRD15 RYR2 RYR3 CCDC93 KIF11 SYNE1 RIF1 MICAL2 APOL3	2.28e-05	168	312	9	30631154
Pubmed	Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach.	PSMA2 PSMA5 PSMC4 DPM1 GTF3C3 FANCD2 CEPT1 POLE SLC25A1 ASS1	2.32e-05	211	312	10	17314511
Pubmed	P-Rex1 and Vav1 cooperate in the regulation of formyl-methionyl-leucyl-phenylalanine-dependent neutrophil responses.	PREX1 VAV1 PREX2	2.44e-05	7	312	3	21178006
Pubmed	P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration.	PREX1 PREX2 MTOR	2.44e-05	7	312	3	17565979
Pubmed	Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.	MAGEA2 MAGEA12 MECP2	2.44e-05	7	312	3	17634428
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	ERCC2 PPP1R12A PSMA5 PTDSS1 DPM1 GTF3C3 CLPTM1L NOP9 URB1 CEPT1 WDR75 A2ML1 TASOR NCAPD3 RTCB TBL3 RIF1 ANKRD17 FUS CSNK2A3 TOP2B	3.13e-05	847	312	21	35850772
Pubmed	Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.	ERCC2 ITGAE NOD1 MMP9 RAG1 POLE XRCC1 P2RX7 EGFR	3.75e-05	179	312	9	19074885
Interaction	ABCA13 interactions	ABCA4 ABCA13 ABCA9 FANCD2 CLK1 ABCA5	3.93e-07	20	308	6	int:ABCA13
Interaction	NR3C1 interactions	ABCA4 RPS6KA5 RYR2 FER1L6 CLPTM1L NF1 WDR75 H4C1 NFKB2 GLS C3 HFM1 MACROH2A2 IL17RA ANKRD52 PREX1 LRRC41 KPNA1 AMPD1 ATG16L1 NCAPD3 HSDL2 POLE SMCHD1 SMARCAL1 BABAM2 PREPL TBL3 AKR7A2 EGFR APOL3 OTOP1 ANKRD17 HADHA EPAS1 NOMO3	9.27e-07	974	308	36	int:NR3C1
Interaction	GPR17 interactions	TBC1D9B CAND2 FANCA FANCD2 URB1 EIF2B5 EXOC7 LRRC41 IPO8 CIP2A DEGS1 RIF1 VAC14 THADA MTOR MFSD5	8.07e-06	283	308	16	int:GPR17
Interaction	TNFSF13B interactions	CAND2 FANCD2 MALT1 NF1 NFKB2 EIF2B5 EXOC7 IPO8 CIP2A MTOR	1.47e-05	119	308	10	int:TNFSF13B
Interaction	FPR1 interactions	TBC1D9B FANCA FANCD2 URB1 EXOC7 IPO8 CIP2A NOMO1 RIF1 THADA MTOR	1.66e-05	147	308	11	int:FPR1
GeneFamily	ATP binding cassette subfamily A	ABCA4 ABCA13 ABCA9 ABCA8 ABCA6 ABCA5	8.63e-09	14	221	6	805
GeneFamily	C3 and PZP like, alpha-2-macroglobulin domain containing	CD109 A2ML1 C3	1.43e-04	9	221	3	1234
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	4.43e-04	3	221	2	287
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	RFK ASIC2 ADGRB3 ELFN2 RHOU RYR2 TBC1D24 URB1 EML5 NFIL3 GLS HPCAL4 CACNA1C ANK1 SLITRK4 FHOD3 VAT1L FRY SHANK2 LGI2 PLXNA4 ZFHX2 SORCS3 PRKCB ZFHX3	1.33e-06	703	312	25	M39070
Coexpression	GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN	TLR8 PARP9 IPO8 RTCB HSDL2 DDX60 SMARCAL1 IFI44 HADH EIF2AK2 ELP4 MX2	5.19e-06	199	312	12	M3311
Coexpression	SHIPP_DLBCL_CURED_VS_FATAL_DN	TBL3 ABCG1 SLC8A3 GUCY2C PRKCB HADHA	1.31e-05	44	312	6	M11685
Coexpression	BROWNE_HCMV_INFECTION_48HR_DN	MAGEA12 TBC1D9B ABCA4 ACHE VDR CACNA1C IPO8 ANK1 SLC7A7 RIF1 ABCA6 MICAL2 ZFHX3 BSCL2 OSMR MUC6 EPAS1 CXCR2	2.20e-05	482	312	18	M12144
Coexpression	KAUFFMANN_DNA_REPAIR_GENES	ERCC2 FANCA FANCD2 MGMT RAD51B POLE MSH4 XRCC1 RIF1 MTOR SUPT16H TOP2B	2.23e-05	230	312	12	M11563
Coexpression	GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP	MAGI1 ASH1L DENND1C MGMT FBXO41 ZC3H12A CAMK4 FHOD1 APOL3 ZFHX3 ZMYM6	2.75e-05	198	312	11	M4309
Coexpression	GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP	MOAP1 GTF3C3 EIF2B5 DHX29 CCDC93 RASA1 CIP2A RUFY1 MTM1 SUPT16H ELP4	2.88e-05	199	312	11	M3328
Coexpression	GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN	ANKS1B CEACAM1 MALT1 NFKB2 GLS C3 KIF13B IFI44 THADA ELMO3 CTSH	2.88e-05	199	312	11	M7690
Coexpression	GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN	EXTL2 EML5 PREX1 AMPD1 DDX60 ADGRL1 RGS3 THADA P2RX7 TMLHE SPATA13	3.02e-05	200	312	11	M7157
Coexpression	FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON	CAND2 HIC2 RYR2 RYR3 LRRIQ1 CACNA1C SYNE1 GDA SLC8A3 ABCA5	3.20e-05	166	312	10	M39026
Coexpression	BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP	ACHE PTGER4 CEACAM1 C3 PARP9 MMP9 VDR ZC3H12A DDX60 IFI44 APOL3 OSMR MX2	4.31e-05	286	312	13	M34008
Coexpression	GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP	SLC43A2 ITGAE EML5 WDR75 AMPD1 NOMO1 ELMO3 CLYBL CPNE4 TOP2B	4.33e-05	172	312	10	M2951
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	RFK ASIC2 SLC22A15 ANKS1B LYST RYR2 TBC1D24 MGAT5 KCNK2 PCDH11X HPCAL4 CACNA1C ANK1 SLITRK4 ABCC5 ADGRL1 FHOD3 PREPL FRY SHANK2 LGI2 PLXNA4 ZFHX2 SORCS3 PRKCB ZFHX3 PLCXD3 LPAR2 SPATA13	6.46e-05	1106	312	29	M39071
Coexpression	LAKE_ADULT_KIDNEY_C28_INTERSTITIUM	DST ROCK2 CACNA1C DPYD KALRN SYNE1 UGGT2	7.61e-05	86	312	7	M39247
Coexpression	RIGGI_EWING_SARCOMA_PROGENITOR_UP	PTGER4 CEACAM1 JARID2 MMP9 PREX1 ATG16L1 KALRN FAT3 DUSP6 IFI44 P2RX7 ABCA5 PRKCB MYOM2 CTSH SPATA13	7.91e-05	437	312	16	M15981
Coexpression	ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP	TTC21A CEACAM1 PARP9 DDX60 IFI44 NUB1 EIF2AK2 MX2	9.21e-05	119	312	8	M41139
Coexpression	XIE_ST_HSC_S1PR3_OE_UP	PTGER4 RYR2 PARP9 COL6A3 KALRN DDX60 IFI44 SLC7A7 EIF2AK2 MX2	9.54e-05	189	312	10	M41755
Coexpression	GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN	FCGBP ALDH2 NCAPD3 RASA1 HSDL2 TBL3 SLC25A1 HADHA CTSH MUC6	1.23e-04	195	312	10	M8142
Coexpression	GSE3982_MAST_CELL_VS_BCELL_DN	ABCB7 URB1 DENND4B FBXO41 PLD2 EIF2AK3 SYNE1 RGS3 THADA MX2	1.34e-04	197	312	10	M5437
Coexpression	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP	ERCC2 ITGAE JARID2 CANT1 CACNA1C ABCC5 ADGRL1 ABCG1 MX2 CXCR2	1.40e-04	198	312	10	M3596
Coexpression	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN	MAGEA12 NXPE4 TRPC6 CKAP5 EXTL2 MGAT5 VDR MSH4 FER1L4 SORCS3	1.40e-04	198	312	10	M5307
Coexpression	MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED	TRPM6 SOHLH2 DDX4 SLITRK4 LDHAL6B RCVRN PCDHA5 MSH4 RNF17 SH3D19 PLCE1	1.44e-04	238	312	11	M2020
Coexpression	GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP	HIC2 MOAP1 VAV1 KIF13B PCDHB11 ADGRL1 MICAL2 ASS1 LPAR2 CDC25B	1.46e-04	199	312	10	M5266
Coexpression	GSE42021_TREG_VS_TCONV_PLN_UP	RPS6KA5 CEACAM1 NOD1 DDX60 IFI44 CCKAR APOL3 OSMR EIF2AK2 MX2	1.52e-04	200	312	10	M9572
Coexpression	GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN	RPS6KA5 ABCA13 PPP1R12A IL17RA PREX1 DDX4 KIF13B SMCHD1 RIF1 PPP4C	1.52e-04	200	312	10	M7505
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN	DST EIF2B5 VAV1 SYNE1 SLC7A7 PREPL FRY ABCA6 PRKCB MUC6	1.52e-04	200	312	10	M5204
Coexpression	GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	MCCC1 ACYP1 EXOC7 CCDC93 CACNA1C HSDL2 POLE SMARCAL1 CTSH EIF2AK2	1.52e-04	200	312	10	M7861
Coexpression	GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP	KDM3A DENND1C FANCA NOD1 CLK1 DUSP6 FRY CDC25B TOP2B SPATA13	1.52e-04	200	312	10	M7841
Coexpression	GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP	PSMA2 NFIL3 MMP9 VDR RUFY1 VAC14 FHOD1 HADH CTSH CXCR2	1.52e-04	200	312	10	M5476
Coexpression	GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP	KDM3A WDR46 MCCC1 ITGAE WDR75 CANT1 ATG16L1 ABCC5 ABCG1 PRKCB	1.52e-04	200	312	10	M3035
Coexpression	TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP	RYR3 DST HSDL2 FHOD3 CPB1 EGFR MUC6	1.53e-04	96	312	7	M5549
Coexpression	YOSHIMURA_MAPK8_TARGETS_UP	ASIC2 ACHE ITGAE PTGER4 MECP2 CEACAM1 MGAT5 MGMT PTPRQ MMP9 EXOC7 EIF2AK3 HPCAL4 CACNA1C RAG1 CACNA1S AMPD1 KALRN CAMK4 CPB1 APOB CCKAR SLC8A3 EGFR GUCY2C ASS1 PRKCB HADHA PRKG2 CDC25B CXCR2	1.54e-04	1281	312	31	M1884
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	PPP1R12A CKAP5 MECP2 JARID2 MGAT5 DST TASOR CCDC93 KIF11 ROCK2 DPYD RASA1 SMCHD1 KIF20B EGFR ANKRD17	1.65e-04	466	312	16	M13522
Coexpression	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	DAPK2 PTGER4 BPNT1 DST WDR75 C3 PARP9 KALRN DDX60 CIP2A DUSP6 IFI44 STEAP4 ABCC5 APOL3 HADH OSMR EIF2AK2 ELP4	1.66e-04	616	312	19	MM977
Coexpression	BENPORATH_MYC_MAX_TARGETS	RPS6KA5 PPP1R12A PSMA5 WDR46 PTDSS1 PSMC4 PSMD10 DPM1 JARID2 CEPT1 KIF11 RASA1 GRK4 DEGS1 KIF20B AKR7A2 PPP2R1B FRY PTPA MTOR SUPT16H CDC25B	1.69e-04	775	312	22	M17753
Coexpression	GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP	DAPK2 PTGER4 BPNT1 DST WDR75 C3 PARP9 KALRN DDX60 CIP2A DUSP6 IFI44 STEAP4 ABCC5 HADH OSMR EIF2AK2 ELP4	1.73e-04	567	312	18	M1097
Coexpression	QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP	PARP9 DDX60 IFI44 EIF2AK2 MX2	2.13e-04	46	312	5	M41048
Coexpression	QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP	PARP9 DDX60 IFI44 EIF2AK2 MX2	2.13e-04	46	312	5	M41047
Coexpression	BLALOCK_ALZHEIMERS_DISEASE_DN	ASIC2 ACHE PPP1R12A PSMA5 PTDSS1 ADGRB3 PSMD10 MCCC1 PTGER4 MOAP1 CEPT1 GLS PCDH11X ALDH2 HPCAL4 ROCK2 PGS1 KALRN DUSP6 BABAM2 PREPL DEGS1 THOC5 SHANK2 DYNC2LI1 SORCS3 PRKCB UGGT2 BSCL2 HADH	2.21e-04	1248	312	30	M17728
Coexpression	HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS	CAND2 ADGRV1 FANCA FANCD2 KIF11 CIP2A POLE RGS3 KIF20B AKR7A2 P2RX7 PRKCB HADH ELP4 SPATA13	2.33e-04	432	312	15	MM419
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 ABCA13 ADGRV1 RYR2 RYR3 OTOGL PTPRQ PCDH11X ANK1 KALRN FAT3 MUC5B APOB PKHD1L1 LOXHD1 MYOM2 PLCE1	1.88e-14	184	312	17	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 ABCA13 ADGRV1 RYR2 RYR3 OTOGL PTPRQ PCDH11X ANK1 KALRN FAT3 MUC5B APOB PKHD1L1 LOXHD1 MYOM2 PLCE1	1.88e-14	184	312	17	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 ABCA13 ADGRV1 RYR2 RYR3 OTOGL PTPRQ PCDH11X ANK1 KALRN FAT3 MUC5B APOB PKHD1L1 LOXHD1 MYOM2 PLCE1	1.88e-14	184	312	17	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RGSL1 ABCA13 ANKS1B ADGRV1 CNTN6 OTOGL PTPRQ AIFM3 CACNA1C CIP2A POLE FAT3 PKHD1L1 ABCA5	9.77e-12	162	312	14	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 DAPK2 LYST RHOU CEACAM1 C3 MMP9 KIF13B SYNE1 DDX60 GDA ZFHX3 CXCR2	2.90e-10	172	312	13	d354424c1f861b6607dfd63b9724f4c237b30275
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ASIC2 ADGRB3 ANKS1B RYR2 GLS CACNA1C KALRN SYNE1 FRY SHANK2 ABCA5 MICAL2 PRKCB	1.45e-09	196	312	13	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADGRB3 ANKS1B RYR2 GLS CACNA1C KALRN SYNE1 PREPL FRY SHANK2 ABCA5 MICAL2 PRKCB	1.64e-09	198	312	13	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ASIC2 ANKS1B RYR2 GLS CACNA1C KALRN SYNE1 PREPL FRY SHANK2 ABCA5 MICAL2 PRKCB	1.64e-09	198	312	13	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ADGRB3 ANKS1B RYR2 GLS PCDH11X ROCK2 CACNA1C KALRN SYNE1 PREPL FRY MICAL2 PRKCB	1.64e-09	198	312	13	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	ASIC2 ANKS1B RYR2 GLS CACNA1C KALRN SYNE1 PREPL FRY SHANK2 ABCA5 MICAL2 PRKCB	1.85e-09	200	312	13	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ASIC2 KCNIP3 RYR2 GLS DPYD KALRN CAMK4 FAT3 GDA MICAL2 PRKCB CPNE4	1.08e-08	190	312	12	49e09cdb843b3d889a06a811aa5affae68b25a75
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19 PLXNA4	1.45e-08	195	312	12	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	TRPC6 ADGRB3 ALDH1L1 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19	1.45e-08	195	312	12	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TRPC6 ADGRB3 ANKS1B PRAG1 DST COL6A3 KALRN FAT3 SLC8A3 ABCA6 EGFR PRKCB	1.45e-08	195	312	12	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	Fetal_29-31_weeks-Immune-monocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SLC43A2 RIN3 SLC22A15 TLR8 FMN1 IL17RA PREX1 VAV1 DUSP6 SLC7A7 P2RX7 PRKCB	1.62e-08	197	312	12	8b9a88fb671d5c2b25d291c851e2b8a478f2610c
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 ADGRV1 RYR2 RYR3 CNTN6 OTOGL FAT3 RNF17 PKHD1L1 PLXNA4 SORCS3	3.27e-08	169	312	11	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKAP5 LYST ABCA9 TLR8 RYR2 TASOR ROCK2 KIF13B SUPT16H HADHA TOP2B	4.96e-08	176	312	11	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 LYST RHOU CEACAM1 FANCA C3 MMP9 SYNE1 DEGS1 GDA CXCR2	5.26e-08	177	312	11	065bebd22031f143e90a407f952b444a3f8818c7
ToppCell	facs-Marrow-Granulocytes-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 LYST RHOU CEACAM1 FANCA C3 MMP9 SYNE1 DEGS1 GDA CXCR2	5.26e-08	177	312	11	eb304f20aab075bd17aa3aef819386c0e1a235bd
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	TTC21A CEACAM1 NOD1 PARP9 DDX60 SMCHD1 IFI44 APOL3 NUB1 EIF2AK2 MX2	5.90e-08	179	312	11	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	PRAG1 RYR2 DST C3 CAMK4 MSH4 BABAM2 GDA MICAL2 SH3D19 OSMR	7.81e-08	184	312	11	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19	9.21e-08	187	312	11	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	Hippocampus-Neuronal-Excitatory\|Hippocampus / BrainAtlas - Mouse McCarroll V32	RYR3 GLS HPCAL4 KPNA1 ROCK2 KALRN CAMK4 FAT3 GDA MICAL2 PRKCB	1.03e-07	189	312	11	4b90d181eb0a42814eeb23bc82e52fd3a12392a7
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ADGRB3 ANKS1B ABCA9 ABCA8 C3 COL6A3 ABCA6 EGFR SH3D19 UGGT2 ZFHX3	1.08e-07	190	312	11	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19	1.14e-07	191	312	11	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ADGRB3 ANKS1B ABCA9 ABCA8 C3 COL6A3 EYS ABCA6 EGFR UGGT2 ZFHX3	1.14e-07	191	312	11	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19	1.20e-07	192	312	11	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	ADGRB3 ANKS1B ABCA9 ABCA8 C3 COL6A3 DPYD ABCA6 EGFR UGGT2 ZFHX3	1.34e-07	194	312	11	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TRPC6 ADGRB3 ANKS1B DST COL6A3 KALRN FAT3 SLC8A3 ABCA6 EGFR PRKCB	1.34e-07	194	312	11	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA13 CEACAM3 ADGRB3 ADGRV1 RYR3 OTOGL IL17RA MMP9 FAT3 STEAP4 CXCR2	1.41e-07	195	312	11	19853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ADGRB3 ANKS1B ABCA9 ABCA8 C3 COL6A3 DPYD ABCA6 EGFR UGGT2 ZFHX3	1.41e-07	195	312	11	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA13 CEACAM3 ADGRB3 ADGRV1 RYR3 OTOGL IL17RA MMP9 FAT3 STEAP4 CXCR2	1.41e-07	195	312	11	d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19	1.41e-07	195	312	11	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	mild-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PARP9 MMP9 DDX60 SMCHD1 IFI44 STEAP4 DHRS12 NUB1 EIF2AK2 MX2 CXCR2	1.48e-07	196	312	11	ded44b38ea489946e9eedfe752b5a9fde9149c16
ToppCell	severe-Lymphocytic-CD4_T_cells_2\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	KREMEN1 CEACAM3 TLR8 CEACAM1 NFIL3 NINJ1 MMP9 IFI44 STEAP4 MX2 CXCR2	1.56e-07	197	312	11	3b71e523d8a68f131def17233385df371db70db5
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19	1.64e-07	198	312	11	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	Control-Control-Myeloid-immature_Neutrophil\|Control / Disease, condition lineage and cell class	CEP104 DAPK2 CKAP5 FANCD2 MGAT5 CANT1 KIF11 HSDL2 PPP2R1B THADA UGGT2	1.82e-07	200	312	11	118321ac443feb42aee171baccfc4610f00a8822
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19	1.82e-07	200	312	11	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 RYR2 CHRNB3 RYR3 PTPRQ TDRD6 FAT3 MUC5B PKHD1L1 TRAPPC3L	2.02e-07	160	312	10	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRV1 RYR2 CHRNB3 RYR3 PTPRQ TDRD6 FAT3 MUC5B PKHD1L1 TRAPPC3L	2.02e-07	160	312	10	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	COVID-19_Severe-CD4+_T_activated\|COVID-19_Severe / Disease condition and Cell class	B3GALNT1 PARP9 CAMK4 DDX60 SMCHD1 IFI44 RNF17 MAPK4 EIF2AK2 MX2	2.85e-07	166	312	10	0f138dbafad6f83975944e8f6398411127b150cc
ToppCell	Control\|World / group, cell type (main and fine annotations)	MAGI1 DAPK2 ANKS1B ADGRV1 PEBP4 SYNE1 STEAP4 SHANK2 EGFR MICAL2	3.19e-07	168	312	10	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACTN3 FKTN FMN1 AIFM3 IL17RA DHX29 PCDHB11 EGFR GSDMA	5.45e-07	137	312	9	e9b88ad86b75454a8292a94879c5b665adc42744
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TRPC6 ADGRB3 ABCA8 RYR2 CACNA1C COL6A3 FAT3 PREX2 ABCA6 SH3D19	6.33e-07	181	312	10	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	DAPK2 ANKS1B CEACAM6 ADGRV1 CNTN6 PEBP4 SHANK2 EGFR MICAL2 MAPK4	7.00e-07	183	312	10	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	ASH1L DST PARP9 DDX60 SMCHD1 IFI44 RIF1 NUB1 EIF2AK2 MX2	7.00e-07	183	312	10	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 DAPK2 CEACAM6 CNTN6 DST PTPRQ SHANK2 EGFR MICAL2 PLCE1	7.35e-07	184	312	10	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MAGI1 DAPK2 CEACAM6 CNTN6 DST PTPRQ SHANK2 EGFR MICAL2 PLCE1	7.35e-07	184	312	10	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAGI1 DAPK2 CEACAM6 CNTN6 DST PTPRQ SHANK2 EGFR MAPK4 PLCE1	7.73e-07	185	312	10	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KCNIP3 RYR2 LRRIQ1 DPYD KALRN FAT3 GDA MICAL2 PRKCB CPNE4	8.12e-07	186	312	10	84ba666237c18189d7e7556bd92dd953af733c00
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ADGRB3 ANKS1B ABCA9 ABCA8 C3 COL6A3 ABCA6 EGFR UGGT2 ZFHX3	8.52e-07	187	312	10	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD109 ADGRB3 CEACAM1 NOD1 PREX1 KALRN PREX2 ABCG1 APOL3 EPAS1	8.52e-07	187	312	10	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CEACAM1 NOD1 PARP9 DDX60 SMCHD1 IFI44 APOL3 NUB1 EIF2AK2 MX2	8.95e-07	188	312	10	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	PPP1R12A ANKS1B RYR2 RYR3 GLS CACNA1C KALRN FAT3 FRY MICAL2	8.95e-07	188	312	10	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRPM6 KREMEN1 CEACAM3 TLR8 MMP9 PGS1 SMCHD1 STEAP4 MX2 CXCR2	8.95e-07	188	312	10	aa46073e2940dc1d2020b2e259bf0fc06cb990ee
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TRPM6 KREMEN1 CEACAM3 TLR8 MMP9 PGS1 SMCHD1 STEAP4 MX2 CXCR2	8.95e-07	188	312	10	04814b78da936a51a497e23060d19ca0d619e250
ToppCell	cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CEACAM3 NFIL3 EIF4E3 IL17RA MMP9 PREX1 SMCHD1 PRKCB MX2 CXCR2	9.39e-07	189	312	10	fedab592be1d6520325b8c1b659b0a4dc3f4fe4d
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	B3GALNT1 PREX1 KALRN SYNE1 PREX2 FRY APOL3 PLCXD3 EPAS1 SPATA13	9.39e-07	189	312	10	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	PBMC-Severe-Myeloid-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRPM6 KREMEN1 ABCA13 CEACAM3 CEACAM6 CEACAM1 MMP9 PGS1 STEAP4 CXCR2	9.85e-07	190	312	10	cb62ece5929896dfba30a4f563c6ba5a5712b71e
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ASIC2 RYR2 GLS KALRN CAMK4 FAT3 GDA MICAL2 PRKCB CPNE4	9.85e-07	190	312	10	d594da827e3c16644952b9589cc12b947ce36279
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RIN3 ADGRB3 JARID2 FMN1 IL17RA PREX1 VAV1 DPYD PRKCB MX2	1.03e-06	191	312	10	47a2afc4102199b4bc76bd01b2967c8016186462
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	ADGRB3 ANKS1B ABCA9 ABCA8 C3 COL6A3 ABCA6 EGFR UGGT2 ZFHX3	1.08e-06	192	312	10	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ASIC2 RYR2 DPYD KALRN CAMK4 FAT3 GDA MICAL2 PRKCB CPNE4	1.08e-06	192	312	10	5c7e8b80b44d9ce55c797cdf8267ac5382e26cac
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRB3 ABCA9 RYR2 DST CACNA1C COL6A3 FAT3 PREX2 ABCA6 SH3D19	1.14e-06	193	312	10	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	ASK440-Epithelial-Secretory\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	CEACAM6 CNTN6 SERPINB4 PTPRQ NINJ1 STEAP4 ABCC5 MUC5B EGFR ASS1	1.14e-06	193	312	10	50e98d91697c7af6a3de39e52edde6dd2b67b512
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	ADGRB3 ANKS1B ABCA9 ABCA8 C3 COL6A3 ABCA6 EGFR UGGT2 ZFHX3	1.14e-06	193	312	10	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRB3 ALDH1L1 ABCA9 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19	1.19e-06	194	312	10	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	MAGI1 DAPK2 RYR2 MGAT5 CACNA1C FHOD3 RGS3 FRY MYOM2 MAPK4	1.19e-06	194	312	10	c3535f7cc0076653c72db582047cff053c322397
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRB3 ABCA8 RYR2 DST CACNA1C COL6A3 KALRN FAT3 ABCA6 PRKCB	1.19e-06	194	312	10	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	ADGRB3 ABCA9 ABCA8 C3 COL6A3 ABCA6 EGFR SH3D19 UGGT2 ZFHX3	1.19e-06	194	312	10	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRB3 RYR2 DST CACNA1C COL6A3 FAT3 LGI2 FHOD1 PRKCB PLCE1	1.19e-06	194	312	10	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	MAGI1 DAPK2 RYR2 DST CACNA1C FHOD3 FRY PLCXD3 MYOM2 MAPK4	1.25e-06	195	312	10	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	facs-Thymus-nan-3m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC43A2 KREMEN1 LYST IL17RA KIF11 RAG1 CAMK4 ABCC5 PRKCB TOP2B	1.25e-06	195	312	10	79114b3c78cc15c413bb58f0673e7215b784a9b6
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ADGRB3 ANKS1B ABCA9 ABCA8 C3 COL6A3 ABCA6 EGFR UGGT2 ZFHX3	1.25e-06	195	312	10	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST COL6A3 FAT3 ABCA6 SH3D19	1.25e-06	195	312	10	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST COL6A3 FAT3 ABCA6 SH3D19	1.25e-06	195	312	10	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	PARP9 RTCB DDX60 SMCHD1 IFI44 ADGRL1 APOL3 NUB1 EIF2AK2 MX2	1.25e-06	195	312	10	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DAPK2 PTGER4 ABCA9 KCNK2 COL6A3 CAMK4 LOXHD1 ABCA6 PRKCB PLCXD3	1.31e-06	196	312	10	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DAPK2 PTGER4 ABCA9 KCNK2 COL6A3 CAMK4 LOXHD1 ABCA6 PRKCB PLCXD3	1.31e-06	196	312	10	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19	1.31e-06	196	312	10	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6 SH3D19	1.31e-06	196	312	10	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ADGRB3 ABCA8 DST CACNA1C COL6A3 DPYD FAT3 ABCA6 SH3D19 PRKCB	1.37e-06	197	312	10	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ADGRB3 ABCA8 DST CACNA1C COL6A3 DPYD FAT3 ABCA6 SH3D19 PRKCB	1.37e-06	197	312	10	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RIN3 FMN1 IL17RA PREX1 VAV1 DPYD SLC7A7 P2RX7 PRKCB MX2	1.43e-06	198	312	10	ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD109 ADGRB3 CEACAM1 PREX1 KALRN SYNE1 PREX2 ABCG1 APOL3 EPAS1	1.43e-06	198	312	10	440af8f90c7afa1c07000806bcf9110b70f489fb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD109 ADGRB3 CEACAM1 PREX1 KALRN SYNE1 PREX2 ABCG1 APOL3 EPAS1	1.43e-06	198	312	10	1378c6d4ceb84b42fdd6556be3296df7a8059e6e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CD109 ADGRB3 CEACAM1 PREX1 KALRN SYNE1 PREX2 ABCG1 APOL3 EPAS1	1.43e-06	198	312	10	451003a21162eeae90739fdb502bb50b362d80c8
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ADGRB3 ABCA8 DST CACNA1C COL6A3 DPYD KALRN FAT3 ABCA6 PRKCB	1.43e-06	198	312	10	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ASIC2 RYR2 GLS CACNA1C KALRN SYNE1 FRY SHANK2 ABCA5 MICAL2	1.43e-06	198	312	10	4ca5ff320905ab4ff60ed90a5522227c782142a6
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	CD109 ADGRB3 CEACAM1 PREX1 CACNA1C IFI44 PREX2 ABCG1 APOL3 EPAS1	1.43e-06	198	312	10	8689090bce9ab6e8f122426a404037e572c6713b
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ASIC2 ANKS1B RYR2 GLS CACNA1C KALRN PREPL FRY SHANK2 ABCA5	1.43e-06	198	312	10	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 DAPK2 MCCC1 ADGRV1 PEBP4 FMN1 SHANK2 EGFR MICAL2 CTSH	1.50e-06	199	312	10	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 DAPK2 MCCC1 ADGRV1 PEBP4 FMN1 SHANK2 EGFR MICAL2 CTSH	1.50e-06	199	312	10	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABCA8 RYR2 DST COL6A3 SYNE1 ABCA6 PLXNA4 SORCS3 OSMR SPATA13	1.50e-06	199	312	10	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	ABCA9 ABCA8 DST CACNA1C COL6A3 KALRN STEAP4 ABCA6 MICAL2 PLCXD3	1.50e-06	199	312	10	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	COVID-19_Severe-Neu_1\|World / 5 Neutrophil clusters in COVID-19 patients	TLR8 NFIL3 PARP9 PGS1 DDX60 SMCHD1 STEAP4 MX2 SPATA13 CXCR2	1.50e-06	199	312	10	e4d8bf016fd95a440e30014a75587e097e90cfad
ToppCell	severe\|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	KREMEN1 CEACAM1 NFIL3 PARP9 MMP9 PGS1 IFI44 STEAP4 EIF2AK2 MX2	1.50e-06	199	312	10	c24aacef7405700bc5d0b736a38feea12b7f17c8
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI1 DAPK2 MCCC1 ADGRV1 PEBP4 FMN1 SHANK2 EGFR MICAL2 CTSH	1.50e-06	199	312	10	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6	1.50e-06	199	312	10	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRPC6 ADGRB3 ABCA9 ABCA8 RYR2 DST CACNA1C COL6A3 FAT3 ABCA6	1.57e-06	200	312	10	389cc775c8419d90fb77cd794376d2160a7bf44e
Drug	ADP-Rib	TRPM6 ERCC2 TRPC6 TNFRSF10D RYR3 FANCD2 NOP9 H4C1 FMN1 NFIL3 NFKB2 PARP9 PLD2 DNASE1L2 XRCC1 RGS3 P2RX7 TOP2B	3.30e-08	269	309	18	CID000000192
Drug	carbachol	RPS6KA5 ACHE PPP1R12A TRPC6 RYR2 CHRNB3 RYR3 NOD1 H4C1 NFKB2 MACROH2A2 PLD2 MMP9 ROCK2 CACNA1C CACNA1S NPR2 TPCN2 IFI44 RGS3 CCKAR EGFR GUCY2C PRKCB PLCXD3 BSCL2 PRKG2 MAPK4 PLCE1	7.79e-08	688	309	29	CID000002551
Drug	genistein	ERCC2 RPS6KA5 PDE6B KCNIP3 ITGAE RYR2 RYR3 DST MGMT H4C1 NFKB2 C3 PLD2 MMP9 KIF11 VDR ROCK2 CACNA1C CACNA1S COL6A3 NPR2 RASA1 IFI44 STEAP4 ABCC5 APOB PTPA EGFR MTOR APOL3 PRKCB PLCXD3 LPAR2 PRKG2 FUS MAPK4 TOP2B PLCE1	1.90e-07	1117	309	38	CID005280961
Drug	verapamil	ABCB7 ABCF1 ABCA4 ABCA13 ABCA9 ABCA8 RYR2 CHRNB3 RYR3 CLPTM1L CACNA1C CACNA1S TPCN2 ABCC5 APOB ABCG1 ABCA6 EGFR ABCA5 APOL3 PRKCB TOP2B MX2	2.86e-07	490	309	23	CID000002520
Drug	lysosphingomyelin	PPP1R12A RYR2 RYR3 PLD2 ROCK2 ANK1 SLC7A7 P2RX7 PRKCB PLCXD3 LPAR2 MAPK4 PLCE1	3.03e-07	160	309	13	CID000005263
Drug	AC1L1JYL	RFK RPS6KA5 PPP1R12A PLD2 ROCK2 NPR2 ANK1 RASA1 DUSP6 IFI44 SLC7A7 RGS3 DEGS1 ABCG1 EGFR MTOR PRKCB PLCXD3 LPAR2 MAPK4 PLCE1	5.84e-07	434	309	21	CID000005262
Drug	myo-inositol	TRPC6 PTGER4 RYR2 CHRNB3 RYR3 BPNT1 NOP9 CEPT1 NF1 PLD2 EIF2AK3 PREX1 VAV1 CACNA1C CACNA1S RASA1 IFI44 RGS3 CCKAR AKR7A2 P2RX7 EGFR MTOR PRKCB PLCXD3 LPAR2 BSCL2 HADHA MAPK4 PLCE1	7.45e-07	811	309	30	CID000000892
Drug	guanine	MAGI1 RIN3 PTGER4 TLR8 RHOU NOP9 BNIP2 NF1 MGMT EIF2B5 C3 PLD2 EXOC7 PREX1 VAV1 KIF13B AMPD1 IPO8 RASA1 XRCC1 PREX2 CCKAR GDA P2RX7 MTOR FHOD1 SH3D19 PLCXD3 BSCL2 FUS CXCR2 PLCE1	7.75e-07	902	309	32	CID000000764
Drug	phorbol acetate myristate	RPS6KA5 PDE6B PSMA5 ITGAE PTGER4 RYR2 RYR3 PEBP4 MALT1 NOP9 NF1 DST H4C1 NFKB2 MACROH2A2 PLD2 MMP9 EIF2AK3 VAV1 VDR ROCK2 CACNA1C CACNA1S ANK1 RASA1 CAMK4 POLE IFI44 STEAP4 APOB AKR7A2 PTPA EGFR MTOR SH3D19 PRKCB PLCXD3 PRKG2 MAPK4 EIF2AK2 CXCR2 PLCE1	1.15e-06	1399	309	42	CID000004792
Drug	glibenclamide	ABCB7 ABCA4 ABCA13 ABCA9 ABCA8 KCNK2 ROCK2 CACNA1C NPR2 ABCC5 APOB ABCG1 ABCA6 ABCA5 GUCY2C APOL3 PRKCB HADH PRKG2	1.35e-06	382	309	19	CID000003488
Drug	dichloromethanediamine	ERCC2 TNFRSF10D FANCA FANCD2 MALT1 MGMT NOMO2 SERPINB4 NFKB2 RAD51B DPYD STEAP4 ABCC5 XRCC1 BABAM2 RIF1 EGFR MTOR SUPT16H PRKCB FUS MAPK4 TOP2B	1.48e-06	539	309	23	CID005311048
Drug	docetaxel	ABCA4 ABCA9 ABCA8 MMP9 DPYD ABCC5 ABCG1 ABCA6 EGFR ABCA5 PRKCB	2.09e-06	133	309	11	ctd:C067311
Drug	lercanidipine	RYR2 RYR3 MMP9 CACNA1C CACNA1S TPCN2 ANK1 DEGS1	2.13e-06	63	309	8	CID000065866
Drug	Go6976	PPP1R12A PSMA5 NFKB2 PLD2 EIF2AK3 CACNA1C IFI44 PTPA EGFR PRKCB PRKG2 MAPK4 CDC25B	2.14e-06	190	309	13	CID000003501
Drug	sultriecin	PTPA PPP4C TOP2B	2.48e-06	3	309	3	CID006439320
Drug	Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; PC3; HT_HG-U133A	B3GALNT1 CEP104 TBC1D8B CEPT1 GLS MMP9 LRRC41 ROCK2 ZC3H12A DUSP6 RIF1 EGFR EIF2AK2	3.02e-06	196	309	13	7271_UP
Drug	Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; MCF7; HT_HG-U133A	LYST ABCA8 CHRNB3 URB1 NOD1 NF1 FBXO41 VDR RGS3 THOC5 CCKAR MUC6 PLCE1	3.38e-06	198	309	13	3583_UP
Drug	AC1NUZ8M	RYR3 NFKB2 CACNA1C CACNA1S NPR2 TPCN2 NAA50 GUCY2C PRKG2	4.50e-06	92	309	9	CID000073211
Drug	papaverine	PDE6B RYR2 RYR3 DST PLD2 DDX4 CACNA1C CACNA1S NPR2 GUCY2C PLCXD3 PLCE1	5.47e-06	176	309	12	CID000004680
Drug	AC1L1JVU	TRPC6 RYR3 NOP9 ROCK2 CACNA1C CACNA1S NAA50 PRKCB	5.92e-06	72	309	8	CID000005229
Drug	Clorocruoro Hem	ACHE TRPC6 RYR2 RYR3 PLD2 ROCK2 CCKAR PLCXD3 MAPK4 PLCE1	7.11e-06	123	309	10	CID003518809
Drug	indo-1/AM	ADGRV1 RYR2 RYR3 NPR2 PRKG2	7.59e-06	21	309	5	CID000123918
Drug	platinum	ERCC2 FANCD2 DPYD ABCC5 XRCC1 BABAM2 RIF1 PPP4C EGFR ASS1 SUPT16H TOP2B	8.14e-06	183	309	12	CID000023939
Drug	U46619	PPP1R12A PTGER4 RYR2 RYR3 NOP9 ROCK2 CACNA1C CACNA1S NPR2 LDHAL6B GUCY2C PRKCB PLCXD3 HADHA PLCE1	9.09e-06	285	309	15	CID000005618
Drug	Succimer	RPS6KA5 ACHE CD109 ASH1L ALDH1L1 TBC1D8B MECP2 MALT1 CEPT1 ALKBH8 H4C1 CLK1 FMN1 SERPINB12 NFKB2 ATP11C C3 NINJ1 MMP9 KIF11 DPYD ZC3H12A DUSP6 IFI44 STEAP4 NAA50 KIF20B GDA RIF1 ABCG1 EGFR MICAL2 PRKCB FUS CTSH EIF2AK2 SPATA13	9.34e-06	1264	309	37	ctd:D004113
Drug	8-Br	PPP1R12A TRPC6 PLD2 NPR2 NAA50 CCKAR PTPA GUCY2C FHOD1 PRKCB PRKG2	9.79e-06	156	309	11	CID000168120
Drug	dehydroilludin M	ERCC2 NAA50 TOP2B	9.80e-06	4	309	3	CID000168782
Drug	AC1Q6AQ7	MAGEA2 MAGEA12 ERCC2 CNTN6 MGMT H4C1 DDX4 ABCC5 ADGRL1 EGFR SUPT16H TOP2B	1.07e-05	188	309	12	CID000005515
Drug	D-myo-inositol-1,4,5-triphosphate	PPP1R12A TRPC6 PTGER4 RYR2 RYR3 NOP9 PLD2 CACNA1C CACNA1S TPCN2 RGS3 CCKAR SLC8A3 EGFR MTOR APOL3 PRKCB PLCXD3 PRKG2 MAPK4 CXCR2 PLCE1	1.16e-05	568	309	22	CID000000806
Drug	3-isoreserpine	ABCB7 ABCF1 ABCA4 ABCA13 ACHE ABCA9 ABCA8 DDX4 ABCC5 ABCG1 ABCA6 ABCA5	1.19e-05	190	309	12	CID000005052
Drug	AC1L1KC5	TRPC6 TNFRSF10D RYR2 CHRNB3 RYR3 NFIL3 PLD2 EIF2AK3 ROCK2 CACNA1C CACNA1S TPCN2 CAMK4 IFI44 STEAP4 CCKAR P2RX7 EGFR PRKCB PRKG2 MAPK4	1.79e-05	541	309	21	CID000005428
Drug	Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; MCF7; HT_HG-U133A	ERCC2 TLR8 RYR2 HPCAL4 ROCK2 ATG16L1 PREX2 MTOR SORCS3 MUC6 MX2 CXCR2	1.80e-05	198	309	12	6496_UP
Drug	Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A	RPS6KA5 MECP2 NF1 GLS EXOC7 KIF13B ATG16L1 NPR2 ADGRL1 OSMR EIF2AK2 ZMYM6	1.80e-05	198	309	12	5286_DN
Drug	NSC750927	MAGEA2 MAGEA12 ERCC2 DAPK2 CEACAM6 MGMT NFKB2 POLE XRCC1 EGFR MTOR SUPT16H PRKCB	1.87e-05	232	309	13	CID000003461
Drug	triazene	MGMT SYNE1 CPB1 XRCC1 EGFR	1.90e-05	25	309	5	CID000115034
Drug	GF109203X	RPS6KA5 PPP1R12A PSMA5 PLD2 ROCK2 IFI44 RGS3 PTPA EGFR MTOR PRKCB PLCXD3 HADHA PRKG2 MAPK4 PLCE1	1.92e-05	341	309	16	CID000002396
Drug	methyl ethyl ketone	RPS6KA5 PSMA5 NF1 NFKB2 IL17RA PLD2 MMP9 EIF2AK3 VDR IPO8 DUSP6 IFI44 LDHAL6B STEAP4 PTPA EGFR MTOR FHOD1 PRKCB LPAR2 PRKG2 MAPK4	1.93e-05	587	309	22	CID000006569
Drug	UTP-NA	RFK ERCC2 GTF3C3 NOP9 CANT1 NFKB2 GLS PLD2 NPR2 POLE IFI44 P2RX7 GUCY2C SUPT16H PLCXD3 MAPK4 CXCR2 PLCE1	1.97e-05	420	309	18	CID000001181
Drug	1-acetyl-sn-glycero-3-phosphocholine	TRPC6 NFKB2 KCNK2 C3 PLD2 IFI44 LDHAL6B APOB SLC7A7 BABAM2 P2RX7 PRKCB LPAR2 MAPK4 CXCR2	2.02e-05	305	309	15	CID005311264
Drug	Magnetite Nanoparticles	B3GALNT1 RPS6KA5 CD109 ASH1L ALDH1L1 TBC1D8B MECP2 MALT1 CEPT1 ALKBH8 H4C1 CLK1 FMN1 SERPINB12 NFKB2 ATP11C C3 NINJ1 MMP9 KIF11 DPYD ZC3H12A DUSP6 IFI44 STEAP4 NAA50 KIF20B GDA RIF1 ABCG1 EGFR MICAL2 PRKCB FUS CTSH EIF2AK2 SPATA13	2.04e-05	1310	309	37	ctd:D058185
Drug	Schiff's reagent	ACHE PSMA5 NOP9 SYNE1 PPP4C	2.32e-05	26	309	5	CID000010484
Drug	phenylarsine oxide	TRPM6 NFKB2 PLD2 EIF2AK3 CACNA1C RASA1 ABCC5 ADGRL1 APOB PTPA EGFR PRKCB MAPK4 EIF2AK2	2.61e-05	275	309	14	CID000004778
Drug	NSC226080	ERCC2 RPS6KA5 PSMA2 PSMA5 PSMC4 RYR2 RYR3 NF1 NFKB2 EIF2B5 PLD2 EIF2AK3 KPNA1 ROCK2 IFI44 NAA50 DEGS1 PREX2 PPP2R1B PTPA PPP4C EGFR MTOR PRKCB MAPK4 EPAS1	2.69e-05	782	309	26	CID000005040
Drug	chelerythrine	PSMA5 TRPC6 CEPT1 PLD2 ROCK2 CACNA1C IFI44 LDHAL6B BABAM2 PTPA SLC9A5 P2RX7 EGFR PRKCB PRKG2 MAPK4	3.34e-05	357	309	16	CID000002703
Drug	hydroxyl radicals	RFK ABCA4 PDE6B ACHE PPP1R12A PSMA5 ALDH1L1 MCCC1 ACYP1 BPNT1 CEPT1 KIF2B CANT1 NFKB2 GLS AIFM3 ATP11C C3 ALDH2 PLD2 COL6A3 DPYD AMPD1 DUSP6 CPA2 GDA PPP2R1B PTPA PPP4C EGFR GUCY2C SLC25A1 MTM1 PRKCB HADHA HADH CDC25B	3.36e-05	1341	309	37	CID000000961
Drug	Pkcs	PPP1R12A PSMA5 MALT1 NFKB2 VAV1 ROCK2 IFI44 EGFR MTOR PRKCB HADHA MAPK4	3.38e-05	211	309	12	CID000164073
Drug	N-methyl-DL-aspartic acid	MAGI1 ACHE ADGRV1 PTGER4 RYR2 CHRNB3 RYR3 NFKB2 GLS EIF2AK3 CACNA1C CACNA1S NPR2 TPCN2 CAMK4 LDHAL6B SHANK2 GUCY2C MTOR PRKCB PRKG2 MAPK4 CXCR2	3.46e-05	655	309	23	CID000004376
Drug	BiM4	RPS6KA5 PPP1R12A PSMA5 NFKB2 PLD2 MMP9 ROCK2 DUSP6 IFI44 EGFR MTOR PRKCB PRKG2 MAPK4	3.58e-05	283	309	14	CID000002399
Drug	Ro 31-8220	RPS6KA5 PPP1R12A PSMA5 NOP9 H4C1 NFKB2 MACROH2A2 PLD2 ROCK2 IFI44 PTPA P2RX7 PRKCB HADHA MAPK4	3.65e-05	321	309	15	CID000005083
Drug	Pilocarpine	ASIC2 ACHE MGMT MMP9 EIF2AK3 VDR CACNA1C ABCC5 XRCC1 P2RX7 EGFR MTOR PRKCB EIF2AK2	3.86e-05	285	309	14	ctd:D010862
Drug	milrinone	PDE6B NFKB2 PLD2 NPR2 SYNE1 ADGRL1 GUCY2C PLCXD3 PRKG2 PLCE1	4.02e-05	150	309	10	CID000004197
Drug	FPL 64176	RYR2 RYR3 CACNA1C CACNA1S	4.04e-05	15	309	4	CID000003423
Drug	BAPTA	TRPC6 RYR2 CHRNB3 RYR3 NFIL3 NFKB2 PLD2 CACNA1C CACNA1S IFI44 P2RX7 PRKCB LPAR2 PRKG2 MAPK4	4.06e-05	324	309	15	CID000104751
Drug	17alpha-estradiol	TRPM6 ERCC2 ACHE TRPC6 PTGER4 RHOU MALT1 BNIP2 H4C1 NFKB2 C3 MACROH2A2 MMP9 KIF11 VDR COL6A3 NPR2 CAMK4 POLE IFI44 LDHAL6B STEAP4 ABCC5 APOB BABAM2 EGFR GUCY2C MTOR APOL3 PRKCB PLCXD3 HADH CTSH TOP2B CXCR2 PLCE1	4.21e-05	1303	309	36	CID000000450
Drug	LS-63783	PPP1R12A TRPC6 PTDSS1 PTGER4 NOP9 DST H4C1 CLK1 NFKB2 KCNK2 C3 MACROH2A2 PLD2 VDR ROCK2 COL6A3 NPR2 IFI44 SLC7A7 DEGS1 ABCG1 GUCY2C PRKCB PLCXD3 HADHA MAPK4	4.29e-05	804	309	26	CID000000231
Drug	2,4,4'-trichlorobiphenyl	MAGI1 ASIC2 ABCA13 ANKS1B FANCA FANCD2 URB1 BNIP2 MGAT5 GLS PCDH11X TDRD6 HPCAL4 RAG1 COL6A3 ANK1 KALRN CAMK4 POLE SMCHD1 FAT3 SLITRK4 CPA2 MSH4 PLEKHD1 BABAM2 KIF20B FRY ELMO3 LOXHD1 SHANK2 MICAL2 FER1L4 MTM1 PLCXD3 LPAR2 CDC25B SPATA13	4.40e-05	1411	309	38	ctd:C081766
Drug	superoxide	FANCD2 NOP9 NFKB2 AIFM3 PLD2 MMP9 EIF2AK3 VAV1 NPR2 IFI44 LDHAL6B NAA50 P2RX7 GUCY2C TMLHE PRKCB HADH MAPK4 CXCR2	4.55e-05	490	309	19	CID000520535
Drug	guanosine 3',5'-cyclic monophosphoric acid	TRPM6 ABCA4 PDE6B ACHE PPP1R12A RYR2 RYR3 MMP9 CACNA1C CACNA1S NPR2 IFI44 RCVRN STEAP4 ABCC5 RNF17 PTPA GUCY2C FHOD1 PRKCB PRKG2	4.56e-05	577	309	21	CID000000295
Drug	erlotinib	PDE6B CEACAM6 NF1 MGMT RASA1 XRCC1 RIF1 EGFR MTOR MAPK4	4.76e-05	153	309	10	CID000176870
Drug	chloro-m-cresol	RYR2 RYR3 CACNA1S	4.80e-05	6	309	3	CID000012008
Drug	NSC114784	RYR2 RYR3 CACNA1S	4.80e-05	6	309	3	CID000419425
Drug	phenytoin	ACHE DAPK2 RYR2 RYR3 MGMT NFKB2 CACNA1C CACNA1S COL6A3 TPCN2 CPB1 LGI2	4.85e-05	219	309	12	CID000001775
Drug	sildenafil	PDE6B ROCK2 NPR2 ABCC5 CPB1 GUCY2C PRKG2 MAPK4	4.95e-05	96	309	8	CID000005212
Drug	eye gene	RPS6KA5 PPP1R12A TRPC6 PLD2 DDX4 VDR ROCK2 CACNA1C NPR2 IFI44 GUCY2C MTOR PRKCB PLCXD3 MAPK4 PLCE1	4.95e-05	369	309	16	CID000004782
Drug	Cocaine	KDM3A RPS6KA5 PPP1R12A CEACAM3 PTDSS1 ANKS1B MECP2 RYR2 RYR3 TBC1D24 BNIP2 NF1 CLK1 NFKB2 ALDH2 PLD2 MMP9 EIF2AK3 HPCAL4 CCDC93 ROCK2 KALRN CAMK4 SYNE1 STEAP4 ABCC5 ADGRL1 PREPL SHANK2 CLYBL EGFR ABCA5 ZFHX2 SORCS3 PRKCB BSCL2	5.01e-05	1314	309	36	ctd:D003042
Drug	AC1L7AJI	ERCC2 ACHE DAPK2 CEACAM3 CNTN6 MGMT DPYD ABCC5 XRCC1 EGFR PRKCB TOP2B MX2	5.19e-05	256	309	13	CID000003750
Drug	BAPTA-AM	TRPC6 RYR3 NFKB2 PLD2 ROCK2 CACNA1C CAMK4 NAA50 P2RX7 EGFR PRKCB LPAR2 PRKG2 MAPK4	5.21e-05	293	309	14	CID000002293
Drug	AC1L1B55	PPP1R12A DAPK2 MOAP1 MGMT NFKB2 MMP9 IFI44 LDHAL6B STEAP4 ADGRL1 APOB ABCG1 EGFR MTOR PRKCB FUS MAPK4 TOP2B	5.43e-05	454	309	18	CID000001287
Drug	KT5720	RPS6KA5 PPP1R12A PTGER4 PLD2 ROCK2 NPR2 TBL3 PTPA GUCY2C PRKCB PRKG2	5.81e-05	189	309	11	CID000003844
Drug	Velcade (bortezomib	PSMA2 PSMA5 PSMC4 TNFRSF10D LYST H4C1 NFKB2 EIF2AK3 IFI44 EGFR MTOR MYOM2 FUS MAPK4 EIF2AK2 TOP2B	5.81e-05	374	309	16	CID000093860
Drug	nifedipine	ABCB7 TRPC6 RYR2 RYR3 EIF2AK3 DDX4 LRRC41 ROCK2 CACNA1C CACNA1S TPCN2 IFI44 LDHAL6B DEGS1 PRKCB HACL1 TOP2B	5.86e-05	415	309	17	CID000004485
Drug	5'-GMP Na2	MAGI1 ERCC2 PDE6B CANT1 NFKB2 ROCK2 NPR2 SYNE1 RCVRN ABCC5 GDA GUCY2C PRKG2 FUS MAPK4	5.93e-05	335	309	15	CID000000761
Drug	2-aminoethyl diphenylborinate	TRPM6 PPP1R12A TRPC6 RYR3 ROCK2 CACNA1C PRKCB LPAR2 FUS	6.07e-05	127	309	9	CID000001598
Drug	AC1L1IHP	RPS6KA5 PPP1R12A PSMA2 PSMA5 PSMC4 NF1 NFKB2 PLD2 KIF11 VDR ROCK2 KIF13B CACNA1C IFI44 STEAP4 APOB PPP2R1B PTPA PPP4C MTOR PRKCB PRKG2 MAPK4 CDC25B	6.31e-05	728	309	24	CID000004584
Drug	N-acetylcysteine	MOAP1 MGMT NFKB2 MMP9 EIF2AK3 NPR2 IFI44 LDHAL6B STEAP4 ABCC5 APOB NAA50 ABCG1 PTPA EGFR GUCY2C MTOR SUPT16H PRKCB MAPK4	6.34e-05	546	309	20	CID000000581
Drug	ethosuximide	RYR2 RYR3 CACNA1C CACNA1S TPCN2 DEGS1 FUS	6.55e-05	74	309	7	CID000003291
Drug	2,4,5,2',5'-pentachlorobiphenyl	MAGI1 ASIC2 ABCA13 ANKS1B FANCA FANCD2 URB1 BNIP2 MGAT5 GLS PCDH11X TDRD6 HPCAL4 RAG1 COL6A3 ANK1 KALRN CAMK4 POLE SMCHD1 FAT3 SLITRK4 CPA2 MSH4 PLEKHD1 BABAM2 KIF20B FRY ELMO3 LOXHD1 SHANK2 MICAL2 FER1L4 MTM1 PLCXD3 LPAR2 CDC25B SPATA13	6.86e-05	1441	309	38	ctd:C009828
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	ASH1L NOD1 NF1 EXOC7 VAV1 RAD51B ATG16L1 PCDHA5 PREX2 PPP2R1B OSMR	7.35e-05	194	309	11	6021_DN
Drug	Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	RIN3 DAPK2 HIC2 FBXO41 EXOC7 VDR CAMK4 ADGRL1 CPB1 MTOR ZMYM6	7.35e-05	194	309	11	4149_DN
Drug	decanoate	PSMA5 PSMD10 AMPD1 NCAPD3 APOB ABCG1 PLCXD3 HADHA PLCE1	7.73e-05	131	309	9	CID000002969
Drug	lonidamine	FANCD2 A2ML1 RIF1 CTSH TOP2B	7.75e-05	33	309	5	CID000039562
Drug	KN-62	RYR3 PLD2 EIF2AK3 CACNA1C CAMK4 IFI44 PTPA P2RX7 PRKCB LPAR2 PRKG2 MAPK4	7.77e-05	230	309	12	CID000003838
Drug	NSC618487	RPS6KA5 DAPK2 PSMA5 CEACAM3 PSMC4 TNFRSF10D H4C1 CLK1 NFKB2 MACROH2A2 PARP9 PLD2 MMP9 ROCK2 CACNA1C ANK1 CAMK4 IFI44 APOB PTPA EGFR PRKCB PLCXD3 PRKG2 MAPK4 TOP2B CXCR2 PLCE1	7.95e-05	933	309	28	CID000005279
Drug	NSC190421	PPP1R12A NFIL3 CACNA1C PPP2R1B PTPA PPP4C	7.99e-05	53	309	6	CID000002545
Drug	Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A	CEP104 MALT1 GLS ATG9A PLD2 ROCK2 NPR2 ADGRL1 RGS3 DHRS12 FHOD1	8.05e-05	196	309	11	7419_DN
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; PC3; HT_HG-U133A	ASIC2 ACTN3 CEACAM1 RAD51B DDX60 IFI44 STEAP4 CPA2 MICAL2 DEPDC5 MX2	8.05e-05	196	309	11	4508_UP
Drug	Dydrogesterone [152-62-5]; Down 200; 12.8uM; PC3; HT_HG-U133A	HIC2 ALDH1L1 FBXO41 VDR IFI44 STEAP4 CCKAR EGFR MTM1 PRKG2 CXCR2	8.05e-05	196	309	11	4254_DN
Drug	C8-ceramide	B3GALNT1 RFK DAPK2 PSMA5 TNFRSF10D NFKB2 C3 PLD2 MMP9 CACNA1C ANK1 IFI44 LDHAL6B APOB DEGS1 PPP2R1B PTPA EGFR PRKCB MAPK4	8.12e-05	556	309	20	CID000002508
Drug	4-epidoxorubicin	ERCC2 PSMA2 PSMA5 TNFRSF10D PEBP4 MALT1 MGMT H4C1 NOMO2 SERPINB4 NFKB2 MACROH2A2 DNASE1L2 ROCK2 POLE LDHAL6B ABCC5 RIF1 EGFR MTOR SUPT16H PRKCB MYOM2 TOP2B MX2	8.17e-05	788	309	25	CID000001690
Drug	4 alpha-phorbol	NOP9 PLD2 EIF2AK3 ROCK2 NPR2 SYNE1 PTPA PRKCB	8.18e-05	103	309	8	CID000028683
Drug	acylfulvene	ERCC2 NAA50 TOP2B	8.32e-05	7	309	3	CID000365701
Drug	Diazoxide [364-98-7]; Down 200; 17.4uM; HL60; HG-U133A	CEACAM3 ITGAE LYST NOD1 NF1 LRRC41 KPNA1 ROCK2 SMARCAL1 TBL3 PTPA	8.43e-05	197	309	11	1368_DN
Drug	Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; MCF7; HT_HG-U133A	ABCB7 MALT1 URB1 NOD1 NF1 GLS PLD2 CCDC93 VDR IPO8 EGFR	8.43e-05	197	309	11	2244_DN
Drug	Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A	ERCC2 CEACAM3 NFKB2 GLS NPR2 CAMK4 MUC5B RNF17 SHANK2 APOL3 DEPDC5	8.43e-05	197	309	11	2307_UP
Drug	Probucol [23288-49-5]; Down 200; 7.8uM; PC3; HT_HG-U133A	CEP104 MECP2 RYR2 NF1 IL17RA PLD2 RAD51B DDX60 STEAP4 RIF1 MICAL2	8.43e-05	197	309	11	4666_DN
Drug	AC1MBZ1C	RPS6KA5 PTGER4 SOHLH2 NFKB2 PLD2 CACNA1C NPR2 CAMK4 IFI44 NAA50 SLC9A5 PRKCB LPAR2 HADHA PRKG2 MAPK4	8.67e-05	387	309	16	CID000003541
Drug	ptaquiloside	ASIC2 ADGRV1 DST MMP9 RAD51B CACNA1C RAG1 FAT3 EGFR	8.69e-05	133	309	9	ctd:C043680
Drug	Barium permanganate	PPP1R12A TRPC6 CACNA1C CACNA1S NPR2 NAA50 P2RX7 GUCY2C PRKCB	8.69e-05	133	309	9	CID000024587
Drug	phosphide	MAGI1 BNIP2 RASA1 PPP4C	8.76e-05	18	309	4	CID005182128
Drug	PD98059	RPS6KA5 PPP1R12A NFKB2 PLD2 VDR ROCK2 IFI44 EGFR MTOR PRKCB PRKG2 MAPK4	8.79e-05	233	309	12	CID000004713
Disease	Colorectal Carcinoma	ERCC2 ABCA4 ABCA13 PSMA2 SLC22A15 CD109 IPP ALDH1L1 ABCA9 ABCA8 NF1 PCDH11X ATP11C ALDH2 CCDC93 DPYD AMPD1 KALRN SYNE1 POLE ABCC5 APOB XRCC1 PREX2 PPP2R1B ABCG1 P2RX7 ABCA6 EGFR ABCA5 GUCY2C PRKCB CTSH	4.02e-13	702	302	33	C0009402
Disease	Colorectal Neoplasms	ERCC2 ABCA4 ABCA13 SLC22A15 CD109 IPP ABCA9 ABCA8 ALDH2 DPYD SYNE1 POLE ABCC5 ABCG1 ABCA6 EGFR ABCA5 GUCY2C PRKCB	9.19e-11	277	302	19	C0009404
Disease	Malignant neoplasm of breast	KDM3A TBC1D9B ABCA4 ACHE CD109 KCNIP3 CNTN6 CLPTM1L NOP9 ALKBH8 NF1 H4C1 FKTN OTOGL PLD2 MMP9 VDR RAD51B DPYD ANK1 KALRN SYNE1 SMARCAL1 LDHAL6B SLC7A7 PLEKHD1 RUFY1 THOC5 CNNM4 RIF1 SLC8A3 EGFR MTOR FUS	6.44e-09	1074	302	34	C0006142
Disease	transient cerebral ischemia (biomarker_via_orthology)	PTGER4 MECP2 NF1 KCNK2 C3 MMP9 ANK1 XRCC1 MTOR	3.69e-05	157	302	9	DOID:224 (biomarker_via_orthology)
Disease	autistic disorder (is_implicated_in)	MECP2 JARID2 NF1 SHANK2 TMLHE	6.78e-05	42	302	5	DOID:12849 (is_implicated_in)
Disease	lung non-small cell carcinoma (is_implicated_in)	ERCC2 CLPTM1L POLE XRCC1 EGFR PRKCB ZFHX3 EPAS1	9.70e-05	139	302	8	DOID:3908 (is_implicated_in)
Disease	urinary bladder cancer (is_implicated_in)	ERCC2 FANCA MGMT MUC5B XRCC1 CXCR2	1.31e-04	76	302	6	DOID:11054 (is_implicated_in)
Disease	Bipolar Disorder	MAGI1 ABCA13 CHRNB3 CNTN6 ALDH2 MMP9 VDR CACNA1C SYNE1 DUSP6 CCKAR PTPA SHANK2 P2RX7 PLCXD3	1.35e-04	477	302	15	C0005586
Disease	Disproportionate short stature	CANT1 WDR35 MMP9 EIF2AK3 NPR2 SMARCAL1	1.41e-04	77	302	6	C0878659
Disease	Glioblastoma Multiforme	NF1 MGMT MMP9 DUSP6 EGFR MTOR PRKCB	1.50e-04	111	302	7	C1621958
Disease	Glioblastoma	NF1 MGMT MMP9 DUSP6 EGFR MTOR	1.62e-04	79	302	6	C0017636
Disease	apolipoprotein B measurement	TDRD15 ERCC2 PSMA5 ABCA9 ABCA8 NF1 CCDC93 KIF13B PGS1 ANK1 APOB XRCC1 BABAM2 THADA ABCA6 DYNC2LI1 FER1L4 ZFHX3	1.87e-04	663	302	18	EFO_0004615
Disease	Giant Cell Glioblastoma	NF1 MGMT MMP9 DUSP6 EGFR MTOR	2.28e-04	84	302	6	C0334588
Disease	Intellectual Disability	PPP1R12A ASH1L MECP2 GTF3C3 ALKBH8 NF1 SYNE1 PREPL FRY SHANK2 MTOR ASS1 SUPT16H ZMYM6	2.34e-04	447	302	14	C3714756
Disease	severe acute respiratory syndrome, COVID-19	MAGI1 RIN3 LYST CNTN6 JARID2 EIF3L PCDH11X COL6A3 PGS1 GRK4 PREX2 EYS ZFHX3 EIF2AK2	2.34e-04	447	302	14	EFO_0000694, MONDO_0100096
Disease	Stomach Neoplasms	ERCC2 WDR46 FCGBP DPYD POLE XRCC1 PTPA EGFR PRKCB MUC6 PLCE1	2.68e-04	297	302	11	C0038356
Disease	Malignant neoplasm of stomach	ERCC2 WDR46 FCGBP DPYD POLE XRCC1 PTPA EGFR PRKCB MUC6 PLCE1	2.92e-04	300	302	11	C0024623
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	3.11e-04	3	302	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	3.11e-04	3	302	2	DOID:8545 (implicated_via_orthology)
Disease	bipolar disorder	ANKS1B ACTN3 PEBP4 H4C1 CACNA1C SYNE1 IFI44 BABAM2 CNNM4 SLC8A3 SHANK2 PLXNA4 GSDMA CDC25B CTSH EPAS1	3.35e-04	577	302	16	MONDO_0004985
Disease	nevus count, cutaneous melanoma	ADGRV1 FANCA JARID2 CLPTM1L FMN1 MX2	3.52e-04	91	302	6	EFO_0000389, EFO_0004632
Disease	skin melanoma (is_implicated_in)	FANCA MMP9 VDR	3.55e-04	14	302	3	DOID:8923 (is_implicated_in)
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 APOB ANKRD17	3.55e-04	14	302	3	EFO_0004611, EFO_0008589
Disease	obesity (implicated_via_orthology)	KDM3A C3 ALDH2 DEGS1 CCKAR THADA GUCY2C ZFHX2 ZFHX3	3.98e-04	215	302	9	DOID:9970 (implicated_via_orthology)
Disease	HETE measurement	MECP2 FER1L6 CNTN6 PCDH11X RAD51B	4.36e-04	62	302	5	EFO_0801166
Disease	response to olanzapine	ANKS1B ADGRV1 CACNA1C	4.41e-04	15	302	3	GO_0097333
Disease	Squamous cell carcinoma of esophagus	MGMT ALDH2 FAT3 XRCC1 EGFR PLCE1	4.43e-04	95	302	6	C0279626
Disease	blood phosphate measurement	RPS6KA5 PRAG1 MGMT PARP9 KPNA1 ATG16L1 ZFHX3 CPNE4	4.49e-04	174	302	8	EFO_0010972
Disease	hepatitis B (is_implicated_in)	VDR ZC3H12A XRCC1 EIF2AK2	5.44e-04	37	302	4	DOID:2043 (is_implicated_in)
Disease	hepatocellular carcinoma (is_implicated_in)	ERCC2 RYR3 CLPTM1L ALDH2 VDR XRCC1 ASS1 ZFHX3	5.82e-04	181	302	8	DOID:684 (is_implicated_in)
Disease	coronary artery disease (is_implicated_in)	ERCC2 MMP9 VDR AMPD1 KALRN APOB	5.83e-04	100	302	6	DOID:3393 (is_implicated_in)
Disease	pancreatic cancer (is_marker_for)	MGMT MMP9 DPYD ABCC5 CCKAR MUC6	6.14e-04	101	302	6	DOID:1793 (is_marker_for)
Disease	Timothy syndrome (implicated_via_orthology)	CACNA1C CACNA1S	6.18e-04	4	302	2	DOID:0060173 (implicated_via_orthology)
Disease	nephrotic syndrome type 20 (implicated_via_orthology)	TBC1D9B TBC1D8B	6.18e-04	4	302	2	DOID:0070357 (implicated_via_orthology)
Disease	nephrotic syndrome type 2 (is_implicated_in)	TRPC6 PLCE1	6.18e-04	4	302	2	DOID:0080379 (is_implicated_in)
Disease	Bladder Neoplasm	ERCC2 ACHE FANCA CLPTM1L MMP9 EGFR MTOR	6.18e-04	140	302	7	C0005695
Disease	common carotid intimal medial thickness	TDRD15 RGSL1 PRAG1 RYR3 APOB	6.25e-04	67	302	5	EFO_0004860
Disease	bipolar I disorder	TDRD15 ANKS1B CACNA1C SYNE1 BABAM2 CNNM4 SHANK2	6.45e-04	141	302	7	EFO_0009963
Disease	Malignant neoplasm of urinary bladder	ERCC2 ACHE FANCA CLPTM1L MMP9 EGFR MTOR	6.45e-04	141	302	7	C0005684
Disease	muscular dystrophy (is_implicated_in)	FKTN COL6A3 SYNE1	6.49e-04	17	302	3	DOID:9884 (is_implicated_in)
Disease	dehydroepiandrosterone sulphate measurement	ABCA13 TRPC6 FAM200A MGMT THADA	6.69e-04	68	302	5	EFO_0007001
Disease	myeloid white cell count	RIN3 TRPC6 EXTL2 FAM200A C3 HFM1 IL17RA PREX1 RAD51B ABCC5 PREX2 DHRS12 THADA MICAL2 SLC25A1 SH3D19 GSDMA ZFHX3 MAPK4 CXCR2 PLCE1	7.22e-04	937	302	21	EFO_0007988
Disease	intraocular pressure measurement	ABCA4 KREMEN1 CKAP5 FANCA MGMT RAD51B COL6A3 KALRN BABAM2 THADA ELMO3 ABCA6 MTOR ZFHX3	8.43e-04	509	302	14	EFO_0004695
Disease	diet measurement, HOMA-B	MAGI1 FAT3 PLXNA4	9.11e-04	19	302	3	EFO_0004469, EFO_0008111
Disease	polycystic kidney disease (biomarker_via_orthology)	MTOR CTSH EPAS1	9.11e-04	19	302	3	DOID:0080322 (biomarker_via_orthology)
Disease	Early Pregnancy Loss	CEACAM6 CEACAM1 SERPINB4 GLS COL6A3 IFI44	9.17e-04	109	302	6	C3830362
Disease	Spontaneous abortion	CEACAM6 CEACAM1 SERPINB4 GLS COL6A3 IFI44	9.17e-04	109	302	6	C0000786
Disease	Miscarriage	CEACAM6 CEACAM1 SERPINB4 GLS COL6A3 IFI44	9.17e-04	109	302	6	C4552766
Disease	Abortion, Tubal	CEACAM6 CEACAM1 SERPINB4 GLS COL6A3 IFI44	9.17e-04	109	302	6	C0000822
Disease	Hereditary Diffuse Gastric Cancer	ERCC2 WDR46 FCGBP DPYD XRCC1 PTPA EGFR PRKCB MUC6 PLCE1	9.45e-04	293	302	10	C1708349
Disease	alcohol use disorder (implicated_via_orthology)	KDM3A RYR2 CHRNB3 RYR3 RASA1 GRK4 EGFR PRKCB	9.45e-04	195	302	8	DOID:1574 (implicated_via_orthology)
Disease	Aneuploidy	CKAP5 KIF11	1.02e-03	5	302	2	C0002938
Disease	mucinous adenocarcinoma (is_marker_for)	ZFHX3 MUC6	1.02e-03	5	302	2	DOID:3030 (is_marker_for)
Disease	marginal zone B-cell lymphoma, systemic lupus erythematosus	MGAT5 KALRN	1.02e-03	5	302	2	EFO_1000630, MONDO_0007915
Disease	aortic valve stenosis (is_implicated_in)	VDR APOB	1.02e-03	5	302	2	DOID:1712 (is_implicated_in)
Disease	pancreatic cancer (is_implicated_in)	ERCC2 FANCA ALDH2 DPYD XRCC1 EGFR	1.06e-03	112	302	6	DOID:1793 (is_implicated_in)
Disease	Malignant Head and Neck Neoplasm	FANCA FANCD2 DPYD EGFR	1.06e-03	44	302	4	C0278996
Disease	esophagus squamous cell carcinoma (is_implicated_in)	FANCA CLPTM1L MGMT XRCC1	1.15e-03	45	302	4	DOID:3748 (is_implicated_in)
Disease	monocyte count	RIN3 PPP1R12A TRPC6 ASH1L DENND1C ADGRV1 LYST TLR8 FANCA NF1 C3 HFM1 EIF4E3 IL17RA PREX1 ZC3H12A IPO8 ANK1 KALRN PREX2 THADA EGFR SLC25A1 NUB1 MAPK4 PLCE1	1.17e-03	1320	302	26	EFO_0005091
Disease	prostate cancer (is_implicated_in)	ERCC2 VDR XRCC1 EGFR MTOR ZFHX3	1.32e-03	117	302	6	DOID:10283 (is_implicated_in)
Disease	Adenocarcinoma of lung (disorder)	TRPM6 CLPTM1L EIF2B5 VAV1 RASA1 CAMK4 EGFR EIF2AK2	1.34e-03	206	302	8	C0152013
Disease	proprotein convertase subtilisin/kexin type 9 measurement	TDRD15 IFI44 APOB	1.42e-03	22	302	3	EFO_0009312
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	RIN3 FANCA H4C1 EIF4E3 DPYD SMCHD1 DUSP6 RUFY1 ZFHX3 CPNE4 PLCE1	1.43e-03	364	302	11	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	gene methylation measurement	MGMT ABCA6	1.52e-03	6	302	2	EFO_0006959
Disease	asphyxia neonatorum (biomarker_via_orthology)	ERCC2 XRCC1	1.52e-03	6	302	2	DOID:11088 (biomarker_via_orthology)
Disease	oral mucosa leukoplakia (is_implicated_in)	ERCC2 XRCC1	1.52e-03	6	302	2	DOID:9655 (is_implicated_in)
Disease	mental or behavioural disorder, substance abuse	MGMT HFM1	1.52e-03	6	302	2	EFO_0000677, MONDO_0002491
Disease	viral load, disease progression measurement, CD4-positive T-lymphocyte count, HIV infection	DPYD IPO8	1.52e-03	6	302	2	EFO_0000764, EFO_0008336, EFO_0010105, EFO_0010125
Disease	lung adenocarcinoma (is_implicated_in)	CLPTM1L XRCC1 EGFR ZFHX3	1.59e-03	49	302	4	DOID:3910 (is_implicated_in)
Disease	Renal glomerular disease	TRPC6 SMARCAL1 PLCE1	1.62e-03	23	302	3	C0268731
Disease	Glomerulopathy Assessment	TRPC6 SMARCAL1 PLCE1	1.62e-03	23	302	3	C4521256
Disease	Noonan Syndrome	NF1 A2ML1 RASA1	1.83e-03	24	302	3	C0028326
Disease	Malignant neoplasm of prostate	RFK ERCC2 ACHE ASH1L CLPTM1L MMP9 DNASE1L2 VDR RAG1 STEAP4 XRCC1 DEGS1 EGFR ZFHX3 EIF2AK2	1.86e-03	616	302	15	C0376358
Disease	Prostatic Neoplasms	RFK ERCC2 ACHE ASH1L CLPTM1L MMP9 DNASE1L2 VDR RAG1 STEAP4 XRCC1 DEGS1 EGFR ZFHX3 EIF2AK2	1.86e-03	616	302	15	C0033578
Disease	Influenza	DDX60 IFI44 EIF2AK2 MX2	1.98e-03	52	302	4	C0021400
Disease	Autism spectrum disorder	MECP2 SHANK2	2.12e-03	7	302	2	cv:C1510586
Disease	Lead Poisoning	MMP9 VDR	2.12e-03	7	302	2	C0023176
Disease	stromal cell-derived factor 1 measurement	ABCA6 ABCA5	2.12e-03	7	302	2	EFO_0020756
Disease	pulmonary venoocclusive disease (biomarker_via_orthology)	EIF2AK3 EIF2AK2	2.12e-03	7	302	2	DOID:5453 (biomarker_via_orthology)
Disease	fatty liver disease (is_implicated_in)	VDR HADHA	2.12e-03	7	302	2	DOID:9452 (is_implicated_in)
Disease	retinal ischemia (biomarker_via_orthology)	PTGER4 MMP9	2.12e-03	7	302	2	DOID:12510 (biomarker_via_orthology)
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	FER1L6 FER1L4	2.12e-03	7	302	2	DOID:11724 (implicated_via_orthology)
Disease	blood rubidium measurement	ABCA13 PREX1 RIF1	2.32e-03	26	302	3	EFO_0021529
Disease	level of Sterol ester (27:1/18:2) in blood serum	TDRD15 APOB ANKRD17	2.32e-03	26	302	3	OBA_2045194
Disease	leukemia	FANCA FANCD2 NF1 MGMT	2.43e-03	55	302	4	C0023418
Disease	macular degeneration (is_implicated_in)	ERCC2 ABCA4 C3	2.59e-03	27	302	3	DOID:4448 (is_implicated_in)
Disease	acute kidney failure (implicated_via_orthology)	PTGER4 MTOR EPAS1	2.59e-03	27	302	3	DOID:3021 (implicated_via_orthology)
Disease	free cholesterol to total lipids in large HDL percentage	TDRD15 MMP9 APOB ABCA6	2.60e-03	56	302	4	EFO_0022279
Disease	Liver Cirrhosis, Experimental	SLC43A2 ACHE ALDH1L1 MGAT5 MGMT GLS EIF4E3 ALDH2 MMP9 VAV1 DUSP6 STEAP4 ABCC5 RGS3 FRY ABCG1 PRKCB	2.80e-03	774	302	17	C0023893
Disease	Muscular Dystrophy	ACHE FKTN	2.81e-03	8	302	2	C0026850
Disease	Chromosomal Instability	CKAP5 KIF11	2.81e-03	8	302	2	C1257806
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	TDRD15 APOB	2.81e-03	8	302	2	EFO_0008589, EFO_0008595
Disease	primary ovarian insufficiency (is_implicated_in)	FANCA MSH4	2.81e-03	8	302	2	DOID:5426 (is_implicated_in)
Disease	diet measurement	TDRD15 ADGRB3 ACTN3 CHRNB3 CNTN6 NF1 DST H4C1 DENND4B ALDH2 ZNF714 DPYD APOB RGS3 THADA PTPA SORCS3 PRKCB ZFHX3 DEPDC5 CPNE4	2.84e-03	1049	302	21	EFO_0008111
Disease	Mammary Carcinoma, Human	ACHE CD109 NOP9 ALKBH8 MMP9 VDR RAD51B DPYD SYNE1 LDHAL6B PLEKHD1 EGFR MTOR	3.18e-03	525	302	13	C4704874
Disease	Mammary Neoplasms, Human	ACHE CD109 NOP9 ALKBH8 MMP9 VDR RAD51B DPYD SYNE1 LDHAL6B PLEKHD1 EGFR MTOR	3.18e-03	525	302	13	C1257931
Disease	Developmental Academic Disorder	ACHE MECP2 NF1	3.19e-03	29	302	3	C1330966
Disease	Learning Disorders	ACHE MECP2 NF1	3.19e-03	29	302	3	C0023186
Disease	Learning Disturbance	ACHE MECP2 NF1	3.19e-03	29	302	3	C0751263
Disease	Adult Learning Disorders	ACHE MECP2 NF1	3.19e-03	29	302	3	C0751262

Protein segments in the cluster

Peptide	Gene	Start	Entry
ADLVSYSIQKVIGFA	VDR	231	P11473
VFKIELYFQAALLGI	ABCA5	1016	Q8WWZ7
ISIAGILYKFQDVLL	ABHD13	51	Q7L211
QVLVGVVKDEGSYFL	ACHE	356	P22303
DVKYFAQEAISVLAL	PPP2R1B	586	P30154
YLKALEGFIAVVTQD	EPAS1	91	Q99814
VYFGLKISQLVDVDE	CHRNB3	56	Q05901
KELFVNADLYIVAGR	ABCF1	316	Q8NE71
TLISVDYEIFGKVQG	ACYP1	6	P07311
EAIALVEKALQAAYG	AKR7A2	271	O43488
KAGQFIIEYLGEVVS	ASH1L	2166	Q9NR48
INFDKYDTILVEVSG	DDX4	266	Q9NQI0
LLESSYKFGDDVVLV	EIF2AK3	181	Q9NZJ5
FLIKNIGLSDSVVYL	ABCA4	166	P78363
LDVENAKLYLDFIVL	ABCG1	641	P45844
ESSVFVLGAVLYKNL	ADGRB3	756	O60242
IQGDLEELKFVAFYT	AIFM3	536	Q96NN9
VDDLGQKITLYLNFV	ALKBH8	106	Q96BT7
YDALQITFTALEGKL	ATG16L1	166	Q676U5
KGVVFDIYEGQITAL	ABCA9	501	Q8IUA7
DYGVSITTLNEVFLK	ABCA9	776	Q8IUA7
AELLFLVGIDKTQYE	ADGRL1	906	O94910
EAVNFATLLYKELTA	ANK1	1221	P16157
DVLLSKEAVGAILYF	GSDMA	321	Q96QA5
LAGVLEYLTANILEK	H2AL3	51	A0A3B3IU63
LKNVYFLLFDSESIG	MACROH2A2	346	Q9P0M6
ALKGLLFDIYEGQIT	ABCA6	496	Q8N139
FGTDTLNIYLDELIK	A2ML1	1396	A8K2U0
EGEELFILKLVSVYG	ADGRV1	1536	Q8WXG9
YNEKGLEVTITARFL	C3	246	P01024
IYLKDVTDFLNIVLT	ABCA13	1461	Q86UQ4
AVKVFLESQGIAYSI	CPA2	76	P48052
LARLGYSDITIFEKQ	DPYD	206	Q12882
EYFATIIKEVGADLV	AMPD1	401	P23109
VVDSRFVLKITDYGL	NPR2	651	P20594
LISLELYQGIKFEAS	CCKAR	231	P32238
YVDVVKVLLESGASI	ANKRD17	346	O75179
AVEFLLYRGKADLTV	ANKRD52	906	Q8NB46
QEIALLKAVLVAGLY	DHX29	1211	Q7Z478
VFYKLLNTVGDLLAQ	DENND1C	106	Q8IV53
DNVTVLIGIAYEGKA	BPNT1	131	O95861
VTKLAYLSDIFGILN	FAM200A	341	Q8TCP9
LLVKSFSESGINYEI	DPM1	46	O60762
VIAYLANIGQKEDFE	ASS1	31	P00966
KYISENILVLDIFFE	ASIC2	396	Q16515
VIAKAFGLQAIDLVY	CLYBL	231	Q8N0X4
FELLGLSTYDFIKEN	CLK1	241	P49759
KLFVESYELILQEGT	MUC5B	956	Q9HC84
SYELILQEGTFKAVA	MUC5B	961	Q9HC84
IGNAAEFYKIFQLEI	RAG1	801	P15918
TSFVYTIKEEGLVLQ	RAD51B	331	O15315
GFVKSDVEINYSLIE	NOMO3	41	P69849
VSIKVNGEYFLSELE	OSMR	381	Q99650
KNLYFILEGSDAQLI	RASA1	491	P20936
LLYEGRNKAAEVTLF	RGS3	576	P49796
SVKDILALILAFGNY	FMN1	1176	Q68DA7
YGIIAQEIILRKETF	GUCY2C	666	P25092
LLKYIEGVSDFNLRV	IPP	236	Q9Y573
DKLIYVFEAEVLTGF	PARP9	756	Q8IXQ6
VKSVINLLFAAYTGD	GLS	551	O94925
AQALKTQDVEYIFGI	HACL1	21	Q9UJ83
IAETFGLQENYIKIV	NUB1	116	Q9Y5A7
AYEIILTLGQAFEVA	ANKS1B	1171	Q7Z6G8
EEVQSKAFFLSILGY	OVOS1	811	Q6IE37
TLDLVELTFKDQYIG	DEPDC5	96	O75140
FDAIAEIGNQLYLFK	MMP9	521	P14780
EGYKFILAEQSTVIN	MUC6	726	Q6W4X9
YVDVVLKFAQFLLTA	IL17RA	391	Q96F46
YSKLQLAELEGEFLV	HOXC12	221	P31275
GAYQAKVLQLLLEAF	NOP9	416	Q86U38
GFVKSDVEINYSLIE	NOMO2	41	Q5JPE7
EAFQKEVELIGASYI	KLHL36	81	Q8N4N3
EVELIGASYIGLKAV	KLHL36	86	Q8N4N3
IYEETRGVLKVFLEN	H4C1	51	P62805
GILNLEEFQQLYIKF	HPCAL4	41	Q9UM19
FSKASEYLQLVFGIE	MAGEA2	151	P43356
FSKASEYLQLVFGIE	MAGEA12	151	P43365
GVDYNFLTVKEFLDL	MAGI1	156	Q96QZ7
LYVKQDSNLVDGFFI	EYS	1921	Q5T1H1
LAVEKYFLLLAEANS	LPAR2	271	Q9HBW0
ILDALKVTANIVFGY	MALT1	476	Q9UDY8
VELIYIDIVGLAQFK	MGAT5	346	Q09328
QVGNDAVFLILYKEL	EIF3L	121	Q9Y262
AADAVKQILEAVAYL	CAMK4	141	Q16566
LQGELFKFSVAYIVQ	MAPK4	91	P31152
NLEHAFYVAEKIGVI	DST	211	Q03001
VTIESVADYFKQIGI	FUS	296	P35637
LLDYVGLDTTKFIVD	HADH	261	Q16836
GTEFSVKVSLLEIYN	KIF11	151	P52732
GIKLIYDAGVSFIVV	SLC43A2	196	Q8N370
DTGFYTLQVIKSDLV	CEACAM6	116	P40199
VKFGEVISYQQLAAL	MGMT	106	P16455
YILTGKVEAEFELLT	FER1L4	1696	A9Z1Z3
LYLIIGATVFKALEQ	KCNK2	71	O95069
DTFIIEAADLGVIYK	LOXHD1	1306	Q8IVV2
TDVFINTGNLVKYLL	B3GALNT1	181	O75752
LVIIGSKYDVFQDFE	DYNC2LI1	181	Q8TCX1
YLVDLISKGGQFTIV	DDX60	71	Q8IY21
VLIGASFFNSKYLEL	EXTL2	211	Q9UBQ6
ELSDLIVFNGKLYSV	CANT1	166	Q8WVQ1
KALVRSDFLLVYGDV	EIF2B5	141	Q13144
ELQILGEISFNKSLY	ITGAE	1086	P38570
GFLQLLVLIKDYEAA	MOAP1	321	Q96BY2
EVGELAKLAYFNDIA	NAA50	41	Q9GZZ1
GVIVSYSNLDDKLFI	PLXNA4	171	Q9HCM2
IKGLYGIDEEVFLSI	LDHAL6B	326	Q9BYZ2
ATEDIRVNKIYGLFV	OR52A5	191	Q9H2C5
IKVYLFDNSVILSGA	PGS1	221	Q32NB8
IDVDLVFGKSAYLFV	PDZD8	206	Q8NEN9
VDKRLAGLTLFAVYA	PTGER4	131	P35408
EFGKFLLSEETLNIY	PDE6B	631	P35913
QFFVYLQEGKVISLL	PEBP4	151	Q96S96
LYLKQGIANLSAEVV	NFIL3	431	Q16649
VVSLLKEVNFYSGIL	CXCR2	121	P25025
LAYDETLNVLKFSAI	KIF20B	461	Q96Q89
GKLLQQDTFYVIELD	KALRN	2121	O60229
GFVKSDVEINYSLIE	NOMO1	41	Q15155
QSKGEEVSEFFLYLL	NOD1	76	Q9Y239
ELIGDYSKAFLLQTV	CDC25B	391	P30305
LNLTVDEGVQVAKYF	ERCC2	706	P18074
VKATQAIYLFELSGE	HSDL2	326	Q6YN16
AQGFAVLYQAVKEEL	KREMEN1	311	Q96MU8
LLFKASYLLEQAEVT	LRRC14B	36	A6NHZ5
IENFELLKVLGTGAY	RPS6KA5	46	O75582
YAAEIAIGLFFLQSK	PRKCB	446	P05771
QLIAEFKRLGSSVIY	POLE	1851	Q07864
LFQVEYAIEAIKLGS	PSMA5	21	P28066
YELIKSQNIFGLDVI	PCDH11X	176	Q9BZA7
GINKEIVYFFSNLVL	PCDHA5	271	Q9Y5H7
NLILDAEGYLKLVDF	PRKG2	581	Q13237
FVKLAQSEYQLLADI	EXOC7	371	Q9UPT5
NASLVGEATVLEKIY	EIF4E3	181	Q8N5X7
LLIENYITGKGDVFT	LRRIQ1	1176	Q96JM4
FYEVKILENSILGSL	PCDHB12	246	Q9Y5F1
QIGVGVLLIFLVKYD	NINJ1	91	Q92982
GIIIAYEVLYKNIDT	PTPRQ	736	Q9UMZ3
FYEVKIRENSILGSL	PCDHB11	246	Q9Y5F2
FVGLDIQQKLTVFYL	HFM1	1081	A2PYH4
ILEKAGYFQSITVGV	ABCC5	391	O15440
LAIVEKYIQNLFIFE	OTOP1	431	Q7RTM1
GKFDIIQLVVYIGST	P2RX7	326	Q99572
LSFLKTIQEVAGYVL	EGFR	76	P00533
KLTEILELLVAAGYF	CCDC93	26	Q567U6
EEAKQVLFLDTVYGN	APOB	171	P04114
NAVVQLKGLEAALVY	CKAP5	61	Q14008
GEEFALEITIFNYLK	CD109	761	Q6YHK3
LFIYQSLDAIDGKQA	CEPT1	126	Q9Y6K0
RELKSVYVDAVGQFL	CEP104	111	O60308
QLVRIAKFLGTEDLY	CSNK2A3	241	Q8NEV1
EGKYASIILFALQDT	IFI44	71	Q8TCB0
VGIDLDTAKYILANI	KDM3A	611	Q9Y4C1
IEIALKILGNADYVF	CACNA1C	946	Q13936
IAKILAGYDLALVQE	DNASE1L2	46	Q92874
VVEYDAEGFTKLTLL	BABAM2	286	Q9NXR7
ALELFEQITKGVDYI	EIF2AK2	391	P19525
ESLYEIAGLNKIIQF	CACNA1S	396	Q13698
DTGFYTLQVIKSDLV	CEACAM1	116	P13688
ATSFIKQILDGVNYL	DAPK2	126	Q9UIK4
KALLVADFGLQVSYD	FCGBP	2981	Q9Y6R7
YLKLVQLFVAGDTST	FANCA	1361	O15360
AQLFQYKAVFILEEL	ATG9A	466	Q7Z3C6
KEASQYFILLILTDG	CPNE4	431	Q96A23
FLYDVVKSLAVGEND	COL6A3	61	P12111
ILYLLEKFVAVLGGN	DDX11L8	446	A8MPP1
LIYEVKDGDINGIFT	FAT3	1701	Q8TDW7
LKLLLVFVEYSESNA	FHOD3	211	Q2V2M9
TIKIAILNFDEYALN	FHOD3	981	Q2V2M9
VLTQLGAFYIVKDLD	DEGS1	51	O15121
EKNFAANTLGVYILT	DHRS12	141	A0PJE2
GIFLALDVVNLVYES	APOL3	346	O95236
DIGFYTLQVIKSDLV	CEACAM3	116	P40198
IFLLEDGSLKIYNIT	CNTN6	456	Q9UQ52
LELFRTKVNALTYGE	ELMO3	486	Q96BJ8
FKYVIGTLELLVAEN	BNIP2	191	Q12982
AIGFVKDVANITIYD	CTSH	221	P09668
GIFIQDYKSDIILAF	FKTN	321	O75072
AIQQGVIKLLDAYFA	LYST	2346	Q99698
NLKSIVVQIGIADYF	FBXO41	821	Q8TF61
LIILENTIYLFSKEG	MCCC1	611	Q96RQ3
VGLAKANTLVYEAEL	DENND4B	201	O75064
TIEYLEEVAITFAKG	HADHA	236	P40939
SEAVIQKFLYLGDDR	GDA	421	Q9Y2T3
QVLVTADDYGIIKLF	EML5	531	Q05BV3
DLYAEVIGVLAQAKF	FRY	226	Q5TBA9
KLLQFIQNIIYEEGF	ELP4	226	Q96EB1
LKIEGFLYSDLTVLA	FAM135B	1106	Q49AJ0
TALKLLLVFVEYSEN	FHOD1	221	Q9Y613
IEQFSVVKGIYLDTA	GRK4	481	P32298
GFAEQKQLLEVELYA	BSCL2	171	Q96G97
ADSFYKIAAEALVVL	CAND2	531	O75155
TGLVDEDTFKLIYAQ	KCNIP3	106	Q9Y2W7
DVLEEFGIKYILNVT	DUSP6	226	Q16828
LGKLTISAAFNIVYI	SLC22A15	406	Q8IZD6
EVAAEYFKNTTLLLV	SLC13A4	76	Q9UKG4
VARKLEFDGLYITEQ	RYR2	4606	Q92736
VILYGFLVAKSRQVD	PKD1L1	1761	Q8TDX9
IQVTELLDKLDFYVL	CPB1	201	P15086
TKLSQDYFVLLVGRA	MFSD5	121	Q6N075
KGIYALVAQDVFLLL	KIF2B	326	Q8N4N8
AVFVKGILDYLDNIS	FANCD2	511	Q9BXW9
TAIELAYLGAKVVVV	MICAL2	101	O94851
IGQIFIEKLADYILV	OTOGL	211	Q3ZCN5
EEAKLLVSQGASIYI	PSMD10	186	O75832
KSILYLEGSALVFED	RIN3	121	Q8TB24
LIYIESVRAQVEKFG	JARID2	571	Q92833
EFFLKTYAVGIQQVL	IPO8	291	O15397
VELIAYFEKVGDTSL	MECP2	136	P51608
IEQIVVALGGEFKLY	MTOR	1056	P42345
DITEDFLVQAKTYLG	NTMT1	91	Q9BV86
LIGETKIDLENRFYS	FER1L6	1436	Q2WGJ9
TVFQQILDFIYTGKL	HIC2	91	Q96JB3
GVANVFLESLFYDVK	KIF13B	801	Q9NQT8
QVEGVFYVNDALEKL	RTCB	31	Q9Y3I0
LEYNLIKEISAGTFD	SLITRK4	456	Q8IW52
YDLIQKFGDLEVTVD	VAC14	646	Q08AM6
EFQKDAILAAITEGY	RGSL1	941	A5PLK6
LAYTGFVKLTEVLNR	THADA	1111	Q6YHU6
EYGEFKIAENVLHLV	TMC3	551	Q7Z5M5
NFDETVKDGVTLYLL	SMCHD1	86	A6NHR9
EFDDKYLITGFNTLL	TDRD6	1806	O60522
AFIRVVGSEFVQKYL	PSMC4	226	P43686
GLYKIFDEILVNAAD	TOP2B	101	Q02880
SFSEGEIIILKEYVN	SH3D19	591	Q5HYK7
SFYDSLGKINEIITV	SYNE1	826	Q8NF91
LSIFKQALLGQVVYA	TDRD15	371	B5MCY1
DFGLVLQTLKEYNLA	LRRC41	631	Q15345
LEYLFIEGNKIETIS	LGI2	111	Q8N0V4
YLIIKDIFQDLSVSI	NXPE4	496	Q6UWF7
LTEGVLDLFAVKAVY	PLCE1	931	Q9P212
ELYEVAGIKGIFLAN	SORCS3	491	Q9UPU3
NLDGTLDFKEYVIAL	RCVRN	76	P35243
EKLLGEIIACLQFSY	RIF1	886	Q5UIP0
LIEEAYGLDKIEFLQ	KPNA1	471	P52294
QVGVIDFSLYLKDVQ	RUFY1	276	Q96T51
LIGYNAELIAVFKTL	SMARCAL1	251	Q9NZC9
QDAYLQLFTKLDVAL	PREX1	1076	Q8TCU6
QATDYLKGVASLFVV	SLC9A5	236	Q14940
LAAVAALLKYVEFIQ	MSH4	276	O15457
EKTYALFIGDTVLVD	SUPT16H	396	Q9Y5B9
QASAAFLVSLYIKDI	URB1	2211	O60287
AETVLVLVNAVYFKA	SERPINB12	181	Q96P63
AIIAGNFELAEYIKN	SHANK2	371	Q9UPX8
VLGEYNLFSRKIEEI	TASOR	1021	Q9UK61
QYDKALEIITDFSGI	GTF3C3	341	Q9Y5Q9
FFYEGIKVILQVALA	TBC1D9B	691	Q66K14
IEALKDLVFDIYEGQ	ABCA8	496	O94911
YIEGQKVLSGISFEV	ABCB7	481	O75027
IGNLNTAFEVAEKYL	ACTN3	216	Q08043
ALYVSDKLQAGTVFV	ALDH1L1	846	O75891
LTALYVANLIKEAGF	ALDH2	216	P05091
KGIFVDTNLYFLALT	CLPTM1L	276	Q96KA5
VKIFYSGANIDELIT	CIP2A	131	Q8TCG1
IIETGLAAFTKLYES	NCAPD3	46	P42695
DLLVKYIFTLGDIAQ	NCAPD3	851	P42695
KVQDILAFYLGRLET	CLEC18A	341	A5D8T8
KVQDILAFYLGRLET	CLEC18B	341	Q6UXF7
KVQDILAFYLGRLET	CLEC18C	341	Q8NCF0
SNIVDILYVKDLAFV	CNNM4	416	Q6P4Q7
YFILILQGKVEVEAG	CNNM4	611	Q6P4Q7
AVEKSINAFLIVYLF	ATP11C	286	Q8NB49
TIQDQLVGSEKLFYE	TNFRSF10D	361	Q9UBN6
LKEVFDAAIVAGIQY	RHOU	211	Q7L0Q8
ILVQFVDYGSTAKLT	RNF17	1511	Q9BXT8
LAYALGKDFVTLQER	SNX20	276	Q7Z614
QLATIFGNIEDIYKF	SPATA13	281	Q96N96
ARVFDVFLVEGYKVL	TBC1D24	226	Q9ULP9
GDFISTVIKLNYVFD	PLCXD3	301	Q63HM9
VGKYVTELDLSDNFI	TLR8	61	Q9NR97
YISEEDFKGLINLTL	TLR8	236	Q9NR97
FSAKEENIIYSFLGL	SH3BGR	146	P55822
ENYKNLVFLAGIAVS	ZNF714	6	Q96N38
DRFIVKLAYESDGIV	ZC3H12A	226	Q5D1E8
DRVDFVKLLIEYGVN	TRPM6	451	Q9BX84
KALLENFGFELVIQY	ZFHX2	1441	Q9C0A1
FYRSIEGFEILVQKE	MTM1	396	Q13496
FYDGIKAILQLGLAI	TBC1D8B	671	Q0IIM8
DALDISTKVQLYGVL	PLEKHD1	21	A6NEE1
NDYGLIQIELTKAAF	WDR75	381	Q8IWA0
ADYIGFILTLNEGVK	PTPA	46	Q15257
IVAFGDIYVSKLQAN	RYR3	1826	Q15413
IARKLEFDGLYITEQ	RYR3	4511	Q15413
LQKQFAGYSEEVLDV	TBL3	326	Q12788
DVQDFGKVIYTLSAL	VAV1	101	P15498
TLVQDIFTYAKVLAL	SLC7A7	181	Q9UM01
AIVFVIYDEVVKLLN	SLC25A1	291	P53007
FGEAAEKNLYLSQLI	NF1	71	P21359
SGKLVQIEYALAAVA	PSMA2	16	P25787
AKFYTAEVVLALDAI	ROCK2	191	O75116
DTTLVLVNAIYFKGQ	SERPINB4	171	P48594
YDFLTELTEVLNGKI	STEAP4	86	Q687X5
AQIKFLYEELGLDST	PREPL	701	Q4J6C6
LQKTERDYVGTLEFL	PREX2	31	Q70Z35
FKEDFYGEILNVAIV	RFK	86	Q969G6
TILGEVNLTIKGYNF	PKHD1L1	1251	Q86WI1
LYEENKVIAGFSLLN	VAT1L	306	Q9HCJ6
LALAYFEKAIGDVIA	TTC23L	231	Q6PF05
VATELGYLFILKNQV	TTC21A	336	Q8NDW8
KFDEFQTGILIYELL	PRAG1	1251	Q86YV5
YLDVSVGKIVAALNA	WDR46	301	O15213
VKEAGRDFTYLIVVL	TIMM21	101	Q9BVV7
QITGFEIFELINKYI	ZMYM6	951	O95789
KLIRYVTAFNGELED	XRCC1	561	P18887
EIISQGYNFEKSLLL	ZNF502	96	Q8TBZ5
KDLFVLTYGALVAQL	TRAPPC3L	16	Q5T215
AIFGLSEVKSVVINY	TRPC6	681	Q9Y210
DFYLLEKITFSNLGE	UGGT2	891	Q9NYU1
QFDKVGILTLSDYVL	THOC5	421	Q13769
DVTVGYLADTVQKLF	SOHLH2	26	Q9NX45
ALQKLDLYTAEQAFV	WDR35	706	Q9P2L0
IFDYLSLSAIIDGKI	PPP4C	146	P60510
LFKEVELALGINSGY	PLD2	401	O14939
LVDGFYAAEQVLQKA	TMLHE	271	Q9NVH6
FGQDLFSKTQILYVV	PTDSS1	371	P48651
YGSVLLSAEEFQKLF	TPCN2	386	Q8NHX9
KALLENFGFELVIQY	ZFHX3	1946	Q15911
LTKNEISYIEDGAFL	ELFN2	86	Q5R3F8
ELLGFVNYKTFEIIV	MX2	491	P20592
GDKIARVIVYFVALI	SLC8A3	71	P57103
TEGSLYEFKIAAVNL	MYOM2	776	P54296
YTEVLKLLIQAGYDV	PPP1R12A	211	O14974
GIIEYDDFKLNSSIV	NFKB2	11	Q00653